Healthcare Cold Chain Logistics Market By Product (Vaccines, Pharmaceuticals (High Value Specialities, Biosimilars, Small molecule innovative drugs, Generic, OTC Products, Others), APIs, Controlled Drugs, Biopharmaceuticals, Clinical Trials, Others (First Aid etc.)); By Temperature (15-25°C controlled, Refrigerated 2-8°C, Frozen -24°C, Cryogenic -170°C, Others); By Services (End-to-End Cold Chain Distribution, Time and Temperature-Sensitive Shipments, Temperature-Controlled GDP Vehicles, Packaging, Warehousing, Transportation, Container Solutions, Thermal Pallet Covers and Multiuse Insulation Blankets, Reverse Logistics for Product, Recalls, Returned, and Salvaged Products, GDP Compliant Distribution, Specialized SOP’s, Others); By Application (Regional distributors, Multi-nationals, Others); By Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid nitrogen, Others); By End Users (Hospitals/Clinics, Research Laboratories, Pharmacies, Ambulatory Care Units, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Spain, Germany, Italy, Nordic Countries , Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia), Brazil, Argentina, Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028
Industry Trends
The healthcare sector has been the focus of initiatives and investments from public and private entities owing to the ability of the sector to aid the growth of mankind and care for them in moments of distress. This has led to vital efforts undertaken from various organizations for the development and manufacturing of numerous medicines and products that are helpful in the provision of healthcare. In these initiatives, logistics has played a key part over the years for the proper transfer of medical products from manufacturers to various end users. The developments in the medical supply chain have led to an expansion in the services offered from various market participants. The importance of cold chain logistics has been growing in the healthcare sector owing to the developments in medical research and the increasing demand for temperature control in various forms of medications. The adoption of cold chain logistics is expected to grow in the healthcare industry owing to the significant benefits offered by the market offerings along with increasing development of vaccines for various diseases on the global scale. The global healthcare cold chain logistics market is expected to reach US$ 20.9 billion by 2028, growing at a CAGR of 7.1% over the forecast period.
By Product
The various products that are developed in the healthcare sector have to be transported in a safe manner for optimal operations in the locations of the end user. These factors have made manufacturers to invest more towards the handling and storage of their products across the supply chain. The adoption of healthcare cold chain logistics is observed in the supply process for products including vaccines, pharmaceuticals, controlled drugs, and active pharmaceutical ingredients (APIs) among others. The demand for market offerings related to the transportation of vaccines is expected to grow in the near future owing to the importance of the product in the efforts towards reducing the impact of the novel coronavirus (COVID-19).
By Temperature
The control of temperature with respect to medicinal products has been observed to grow in terms of focus from manufacturers and logistic companies. The demand for high quality and lowering the number of defects during administration has provided an impetus for the adoption of innovative cold chain logistic solutions in the healthcare sector. Market participants are able to provide logistic services to healthcare companies wherein their products can be maintained at temperatures including near to room temperature (15-25 0C), refrigerated (2-8 0C), frozen (Up to -24 0C), and cryogenic temperatures, among others. The characteristics of the target product which is being transported governs the ideal temperature range and is a key focus area during contract discussions among the end users and market participants. The availability of custom services is expected to increase the awareness regarding market offerings among end users and lead the market towards growth over the near future.
By Service
Market participants have been developing a wider range of services for various end users. The notable services offered have been in the dedicated services along with comprehensive services helping the overall supply chain for the end users. The adoption for comprehensive services is observed to be adopted from international distributors. The demand for dedicated services is expected to grow owing to the increasing adoption custom logistic plans from various end users.
By Application
The adopters for the offerings in the market are majorly observed among regional distributors and international distributors. With respect to the expansion of the pharmaceutical sector, the market revenue contribution from international distributors is expected to grow. Regional distributors are expected to focus on supply chain optimization and adopt market offerings in order to increase their presence in their operating region. The demand for market offerings is expected to grow over the years owing to increasing market offerings and innovative marketing initiatives from various companies.
By Storage Techniques
Medical products and pharmaceuticals are observed to be stored in various configurations. Notable storage techniques used in the healthcare logistics sector include electrical refrigeration, dry ice, gel packs, and liquid Nitrogen, among others. The adoption of specific storage techniques is seen to be majorly dependent on the physical and chemical characteristics of the medicine and products to be stored. The use of dry ice has been seen to be helpful in conditions wherein products are transported from distribution locations to the locations where the products are administered. The ability of dry ice in the flash freezing of various products is helpful across various applications in healthcare sector and also across other industries. Electrical refrigeration is observed to be used in cases where in a large amount of medicines are transports in the form of bulk products. Organizations are devising the perfect balance among the various storage techniques and are also producing custom made storage solutions for their products from market participants. These initiatives are expected to help in increasing the demand for offerings in the global healthcare cold chain logistics market.
By End Users
The use of healthcare cold chain logistic solutions and services is observed majorly from organizations including hospitals, clinics, research institutes, private or public pharmacies, and ambulatory care centers, among others. Since these organizations are considered to be a major distribution block in the healthcare supply chain, the need for optimal logistic services is paramount. Hospitals are observed to be major adopters for the offerings in the market owing to the use of a wide range of medicines and allied products in these facilities. Various products require specific temperature conditions for maintaining the integrity of the ingredients, which makes dedicated investments towards the same ever the more important. In addition to this, research laboratories work with various pharmaceuticals and active pharmaceutical ingredients (APIs) which have to be maintained at specific temperatures when transporting for testing and other research-based procedures. The services from the market are observed to be beneficial in such cases, thereby gathering significant investments from various institutions across various countries. With the positive trend towards the creation of vaccines for the novel coronavirus (COVID-19), the investments towards healthcare logistics are expected to grow significantly leading to an influx of revenue for the market over the forecast period.
By Region
The demand for high performance logistic services has been growing across various regions owing to the growing integration of technology in the sector along with initiatives for supply chain optimization from various market participants. In terms of logistics service procurement, North America is observed to be one of the leading regions with various end users in the public and private sector in addition to the various regulations on medical logistics mandating high quality services from various market participants. The region of Asia Pacific is expected to become one of the fastest growing regions in terms of revenue contribution for the market owing to the higher presence of medical device and product manufacturers in the region and the growing ventures of market participants in the countries across the region. Furthermore, the development of the vaccine related to the novel coronavirus (COVID-19) is expected to aid in increasing the demand for market offerings across the countries in the region of Asia Pacific over the near future. These factors are expected to help in growing the revenue generation from the market.
Healthcare Cold Chain Logistics Market Revenue & Forecast, (US$ Million), 2015 – 2028
Competitive Landscape
The report provides both, qualitative and quantitative research of healthcare cold chain logistics market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the healthcare cold chain logistics market are American Airlines, Inc., AmerisourceBergen Corporation, Cardinal Health., CAVALIER LOGISITICS, DB Schenker, DHL International GmbH, FedEx, GLOBAL COLD CHAIN SOLUTIONS PTY LTD, KUEHNE + NAGEL, PAREXEL International Corporation., Quick International Courier, United Parcel Service of America, Inc., Unsworth, Virgin Atlantic Airways Ltd., and YUSEN LOGISTICS CO, LTD among others.
Healthcare Cold Chain Logistics Market:
- By Product
- Vaccines
- Pharmaceuticals
- High Value Specialities
- Biosimilars
- Small molecule innovative drugs
- Generic
- OTC Products
- Others
- APIs
- Controlled Drugs
- Biopharmaceuticals
- Clinical Trials
- Others (First Aid etc.)
- By Temperature
- 15-25°C controlled
- Refrigerated 2-8°C
- Frozen -24°C
- Cryogenic -170°C
- Others
- By Services
- End-to-End Cold Chain Distribution
- Time and Temperature-Sensitive Shipments
- Temperature-Controlled GDP Vehicles
- Packaging
- Warehousing
- Transportation
- Container Solutions
- Thermal Pallet Covers and Multi-Use Insulation Blankets
- Reverse Logistics for Product Recalls, Returned, and Salvaged Products
- GDP Compliant Distribution
- Specialized SOP’s
- Others
- By Application
- Regional distributors
- Multi-nationals
- Others
- By Storage Techniques
- Electrical Refrigeration
- Dry Ice
- Gel Packs
- Liquid Nitrogen
- Others
- By End Users
- Hospitals/Clinics
- Research Laboratories
- Pharmacies
- Ambulatory Care Units
- Others
- By Geography
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2018
1.2.2. Base
Year: 2019
1.2.3. Forecast
Years: 2020 – 2028
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Healthcare Cold Chain Logistics Market
6. Market
Synopsis: Healthcare Cold Chain
Logistics Market
7. Healthcare
Cold Chain Logistics Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Healthcare Cold Chain Logistics Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Healthcare Cold Chain Logistics Market
7.6. Porter’s Five Force Analysis
7.7. Impact of
Covid-19 on Healthcare Cold Chain Logistics Market
8. Global
Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 – 2028
8.1. Overview
8.1.1. Global
Healthcare Cold Chain Logistics Market Revenue (US$ Mn)
8.2. Global
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
8.2.1. Vaccines
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2019
8.2.1.3. Market
Forecast, 2020 – 2028
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2019
8.2.1.5.1.2. Market
Forecast, 2020 – 2028
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2019
8.2.1.5.2.2. Market
Forecast, 2020 – 2028
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2019
8.2.1.5.3.2. Market
Forecast, 2020 – 2028
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2019
8.2.1.5.4.2. Market
Forecast, 2020 – 2028
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2019
8.2.1.5.5.2. Market
Forecast, 2020 – 2028
8.2.2. Pharmaceuticals
(Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation
(2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on High Value Specialities,
Biosimilars, Small molecule innovative drugs, Generic, OTC Products, Others)
8.2.2.1. High
Value Specialities
8.2.2.2. Biosimilars
8.2.2.3. Small
molecule innovative drugs
8.2.2.4. Generic
8.2.2.5. OTC
Products
8.2.2.6. Others
8.2.3. APIs
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2019
8.2.3.3. Market
Forecast, 2020 – 2028
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2019
8.2.3.5.1.2. Market
Forecast, 2020 – 2028
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2019
8.2.3.5.2.2. Market
Forecast, 2020 – 2028
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2019
8.2.3.5.3.2. Market
Forecast, 2020 – 2028
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2019
8.2.3.5.4.2. Market
Forecast, 2020 – 2028
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2019
8.2.3.5.5.2. Market
Forecast, 2020 – 2028
8.2.4. Controlled
Drugs
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 – 2019
8.2.4.3. Market
Forecast, 2020 – 2028
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 – 2019
8.2.4.5.1.2. Market
Forecast, 2020 – 2028
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2019
8.2.4.5.2.2. Market
Forecast, 2020 – 2028
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2019
8.2.4.5.3.2. Market
Forecast, 2020 – 2028
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2019
8.2.4.5.4.2. Market
Forecast, 2020 – 2028
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 – 2019
8.2.4.5.5.2. Market
Forecast, 2020 – 2028
8.2.5. Biopharmaceuticals
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 – 2019
8.2.5.3. Market
Forecast, 2020 – 2028
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 – 2019
8.2.5.5.1.2. Market
Forecast, 2020 – 2028
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 – 2019
8.2.5.5.2.2. Market
Forecast, 2020 – 2028
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 – 2019
8.2.5.5.3.2. Market
Forecast, 2020 – 2028
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 – 2019
8.2.5.5.4.2. Market
Forecast, 2020 – 2028
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 – 2019
8.2.5.5.5.2. Market
Forecast, 2020 – 2028
8.2.6. Clinical
Trials
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2015 – 2019
8.2.6.3. Market
Forecast, 2020 – 2028
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market
Estimation, 2015 – 2019
8.2.6.5.1.2. Market
Forecast, 2020 – 2028
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 – 2019
8.2.6.5.2.2. Market
Forecast, 2020 – 2028
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market
Estimation, 2015 – 2019
8.2.6.5.3.2. Market
Forecast, 2020 – 2028
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 – 2019
8.2.6.5.4.2. Market
Forecast, 2020 – 2028
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market
Estimation, 2015 – 2019
8.2.6.5.5.2. Market
Forecast, 2020 – 2028
8.2.7. Others
(First Aid etc.)
8.2.7.1. Definition
8.2.7.2. Market
Estimation and Penetration, 2015 – 2019
8.2.7.3. Market
Forecast, 2020 – 2028
8.2.7.4. Compound
Annual Growth Rate (CAGR)
8.2.7.5. Regional
Bifurcation
8.2.7.5.1. North
America
8.2.7.5.1.1. Market
Estimation, 2015 – 2019
8.2.7.5.1.2. Market
Forecast, 2020 – 2028
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 – 2019
8.2.7.5.2.2. Market
Forecast, 2020 – 2028
8.2.7.5.3. Asia
Pacific
8.2.7.5.3.1. Market
Estimation, 2015 – 2019
8.2.7.5.3.2. Market
Forecast, 2020 – 2028
8.2.7.5.4. Middle
East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 – 2019
8.2.7.5.4.2. Market
Forecast, 2020 – 2028
8.2.7.5.5. Latin
America
8.2.7.5.5.1. Market
Estimation, 2015 – 2019
8.2.7.5.5.2. Market
Forecast, 2020 – 2028
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product
9. Global
Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 – 2028
9.1. Overview
9.2. Global
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
9.2.1. 15-25°C controlled
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2019
9.2.1.3. Market
Forecast, 2020 – 2028
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2019
9.2.1.5.1.2. Market
Forecast, 2020 – 2028
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2019
9.2.1.5.2.2. Market
Forecast, 2020 – 2028
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2019
9.2.1.5.3.2. Market
Forecast, 2020 – 2028
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2019
9.2.1.5.4.2. Market
Forecast, 2020 – 2028
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2019
9.2.1.5.5.2. Market
Forecast, 2020 – 2028
9.2.2. Refrigerated
2-8°C
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2019
9.2.2.3. Market
Forecast, 2020 – 2028
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2019
9.2.2.5.1.2. Market
Forecast, 2020 – 2028
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2019
9.2.2.5.2.2. Market
Forecast, 2020 – 2028
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2019
9.2.2.5.3.2. Market
Forecast, 2020 – 2028
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2019
9.2.2.5.4.2. Market
Forecast, 2020 – 2028
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2019
9.2.2.5.5.2. Market
Forecast, 2020 – 2028
9.2.3. Frozen
-24°C
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 – 2019
9.2.3.3. Market
Forecast, 2020 – 2028
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 – 2019
9.2.3.5.1.2. Market
Forecast, 2020 – 2028
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2019
9.2.3.5.2.2. Market
Forecast, 2020 – 2028
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2019
9.2.3.5.3.2. Market
Forecast, 2020 – 2028
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2019
9.2.3.5.4.2. Market
Forecast, 2020 – 2028
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 – 2019
9.2.3.5.5.2. Market
Forecast, 2020 – 2028
9.2.4. Cryogenic
-170°C
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 – 2019
9.2.4.3. Market
Forecast, 2020 – 2028
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 – 2019
9.2.4.5.1.2. Market
Forecast, 2020 – 2028
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2019
9.2.4.5.2.2. Market
Forecast, 2020 – 2028
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2019
9.2.4.5.3.2. Market
Forecast, 2020 – 2028
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2019
9.2.4.5.4.2. Market
Forecast, 2020 – 2028
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 – 2019
9.2.4.5.5.2. Market
Forecast, 2020 – 2028
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 – 2019
9.2.5.3. Market
Forecast, 2020 – 2028
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 – 2019
9.2.5.5.1.2. Market
Forecast, 2020 – 2028
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 – 2019
9.2.5.5.2.2. Market
Forecast, 2020 – 2028
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 – 2019
9.2.5.5.3.2. Market
Forecast, 2020 – 2028
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 – 2019
9.2.5.5.4.2. Market
Forecast, 2020 – 2028
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 – 2019
9.2.5.5.5.2. Market
Forecast, 2020 – 2028
9.3. Key
Segment for Channeling Investments
9.3.1. By Temperature
10. Global
Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 – 2028
10.1. Overview
10.2. Global
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
10.2.1. End-to-End
Cold Chain Distribution
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2019
10.2.1.3. Market
Forecast, 2020 – 2028
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2019
10.2.1.5.1.2. Market
Forecast, 2020 – 2028
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2019
10.2.1.5.2.2. Market
Forecast, 2020 – 2028
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2019
10.2.1.5.3.2. Market
Forecast, 2020 – 2028
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2019
10.2.1.5.4.2. Market
Forecast, 2020 – 2028
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2019
10.2.1.5.5.2. Market
Forecast, 2020 – 2028
10.2.2. Time
and Temperature-Sensitive Shipments
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2019
10.2.2.3. Market
Forecast, 2020 – 2028
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2019
10.2.2.5.1.2. Market
Forecast, 2020 – 2028
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2019
10.2.2.5.2.2. Market
Forecast, 2020 – 2028
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2019
10.2.2.5.3.2. Market
Forecast, 2020 – 2028
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2019
10.2.2.5.4.2. Market
Forecast, 2020 – 2028
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2019
10.2.2.5.5.2. Market
Forecast, 2020 – 2028
10.2.3. Temperature-Controlled
GDP Vehicles
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2019
10.2.3.3. Market
Forecast, 2020 – 2028
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2019
10.2.3.5.1.2. Market
Forecast, 2020 – 2028
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2019
10.2.3.5.2.2. Market
Forecast, 2020 – 2028
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2019
10.2.3.5.3.2. Market
Forecast, 2020 – 2028
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2019
10.2.3.5.4.2. Market
Forecast, 2020 – 2028
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2019
10.2.3.5.5.2. Market
Forecast, 2020 – 2028
10.2.4. Packaging
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 – 2019
10.2.4.3. Market
Forecast, 2020 – 2028
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 – 2019
10.2.4.5.1.2. Market
Forecast, 2020 – 2028
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 – 2019
10.2.4.5.2.2. Market
Forecast, 2020 – 2028
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 – 2019
10.2.4.5.3.2. Market
Forecast, 2020 – 2028
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 – 2019
10.2.4.5.4.2. Market
Forecast, 2020 – 2028
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 – 2019
10.2.4.5.5.2. Market
Forecast, 2020 – 2028
10.2.5. Warehousing
10.2.5.1. Definition
10.2.5.2. Market
Estimation and Penetration, 2015 – 2019
10.2.5.3. Market
Forecast, 2020 – 2028
10.2.5.4. Compound
Annual Growth Rate (CAGR)
10.2.5.5. Regional
Bifurcation
10.2.5.5.1. North
America
10.2.5.5.1.1. Market
Estimation, 2015 – 2019
10.2.5.5.1.2. Market
Forecast, 2020 – 2028
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 – 2019
10.2.5.5.2.2. Market
Forecast, 2020 – 2028
10.2.5.5.3. Asia
Pacific
10.2.5.5.3.1. Market
Estimation, 2015 – 2019
10.2.5.5.3.2. Market
Forecast, 2020 – 2028
10.2.5.5.4. Middle
East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 – 2019
10.2.5.5.4.2. Market
Forecast, 2020 – 2028
10.2.5.5.5. Latin
America
10.2.5.5.5.1. Market
Estimation, 2015 – 2019
10.2.5.5.5.2. Market
Forecast, 2020 – 2028
10.2.6. Transportation
10.2.6.1. Definition
10.2.6.2. Market
Estimation and Penetration, 2015 – 2019
10.2.6.3. Market
Forecast, 2020 – 2028
10.2.6.4. Compound
Annual Growth Rate (CAGR)
10.2.6.5. Regional
Bifurcation
10.2.6.5.1. North
America
10.2.6.5.1.1. Market
Estimation, 2015 – 2019
10.2.6.5.1.2. Market
Forecast, 2020 – 2028
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 – 2019
10.2.6.5.2.2. Market
Forecast, 2020 – 2028
10.2.6.5.3. Asia
Pacific
10.2.6.5.3.1. Market
Estimation, 2015 – 2019
10.2.6.5.3.2. Market
Forecast, 2020 – 2028
10.2.6.5.4. Middle
East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 – 2019
10.2.6.5.4.2. Market
Forecast, 2020 – 2028
10.2.6.5.5. Latin
America
10.2.6.5.5.1. Market
Estimation, 2015 – 2019
10.2.6.5.5.2. Market
Forecast, 2020 – 2028
10.2.7. Container
Solutions
10.2.7.1. Definition
10.2.7.2. Market
Estimation and Penetration, 2015 – 2019
10.2.7.3. Market
Forecast, 2020 – 2028
10.2.7.4. Compound
Annual Growth Rate (CAGR)
10.2.7.5. Regional
Bifurcation
10.2.7.5.1. North
America
10.2.7.5.1.1. Market
Estimation, 2015 – 2019
10.2.7.5.1.2. Market
Forecast, 2020 – 2028
10.2.7.5.2. Europe
10.2.7.5.2.1. Market
Estimation, 2015 – 2019
10.2.7.5.2.2. Market
Forecast, 2020 – 2028
10.2.7.5.3. Asia
Pacific
10.2.7.5.3.1. Market
Estimation, 2015 – 2019
10.2.7.5.3.2. Market
Forecast, 2020 – 2028
10.2.7.5.4. Middle
East and Africa
10.2.7.5.4.1. Market
Estimation, 2015 – 2019
10.2.7.5.4.2. Market
Forecast, 2020 – 2028
10.2.7.5.5. Latin
America
10.2.7.5.5.1. Market
Estimation, 2015 – 2019
10.2.7.5.5.2. Market
Forecast, 2020 – 2028
10.2.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
10.2.8.1. Definition
10.2.8.2. Market
Estimation and Penetration, 2015 – 2019
10.2.8.3. Market
Forecast, 2020 – 2028
10.2.8.4. Compound
Annual Growth Rate (CAGR)
10.2.8.5. Regional
Bifurcation
10.2.8.5.1. North
America
10.2.8.5.1.1. Market
Estimation, 2015 – 2019
10.2.8.5.1.2. Market
Forecast, 2020 – 2028
10.2.8.5.2. Europe
10.2.8.5.2.1. Market
Estimation, 2015 – 2019
10.2.8.5.2.2. Market
Forecast, 2020 – 2028
10.2.8.5.3. Asia
Pacific
10.2.8.5.3.1. Market
Estimation, 2015 – 2019
10.2.8.5.3.2. Market
Forecast, 2020 – 2028
10.2.8.5.4. Middle
East and Africa
10.2.8.5.4.1. Market
Estimation, 2015 – 2019
10.2.8.5.4.2. Market
Forecast, 2020 – 2028
10.2.8.5.5. Latin
America
10.2.8.5.5.1. Market
Estimation, 2015 – 2019
10.2.8.5.5.2. Market
Forecast, 2020 – 2028
10.2.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
10.2.9.1. Definition
10.2.9.2. Market
Estimation and Penetration, 2015 – 2019
10.2.9.3. Market
Forecast, 2020 – 2028
10.2.9.4. Compound
Annual Growth Rate (CAGR)
10.2.9.5. Regional
Bifurcation
10.2.9.5.1. North
America
10.2.9.5.1.1. Market
Estimation, 2015 – 2019
10.2.9.5.1.2. Market
Forecast, 2020 – 2028
10.2.9.5.2. Europe
10.2.9.5.2.1. Market
Estimation, 2015 – 2019
10.2.9.5.2.2. Market
Forecast, 2020 – 2028
10.2.9.5.3. Asia
Pacific
10.2.9.5.3.1. Market
Estimation, 2015 – 2019
10.2.9.5.3.2. Market
Forecast, 2020 – 2028
10.2.9.5.4. Middle
East and Africa
10.2.9.5.4.1. Market
Estimation, 2015 – 2019
10.2.9.5.4.2. Market
Forecast, 2020 – 2028
10.2.9.5.5. Latin
America
10.2.9.5.5.1. Market
Estimation, 2015 – 2019
10.2.9.5.5.2. Market
Forecast, 2020 – 2028
10.2.10. GDP
Compliant Distribution
10.2.10.1. Definition
10.2.10.2. Market
Estimation and Penetration, 2015 – 2019
10.2.10.3. Market
Forecast, 2020 – 2028
10.2.10.4. Compound
Annual Growth Rate (CAGR)
10.2.10.5. Regional
Bifurcation
10.2.10.5.1. North
America
10.2.10.5.1.1. Market
Estimation, 2015 – 2019
10.2.10.5.1.2. Market
Forecast, 2020 – 2028
10.2.10.5.2. Europe
10.2.10.5.2.1. Market
Estimation, 2015 – 2019
10.2.10.5.2.2. Market
Forecast, 2020 – 2028
10.2.10.5.3. Asia
Pacific
10.2.10.5.3.1. Market
Estimation, 2015 – 2019
10.2.10.5.3.2. Market
Forecast, 2020 – 2028
10.2.10.5.4. Middle
East and Africa
10.2.10.5.4.1. Market
Estimation, 2015 – 2019
10.2.10.5.4.2. Market
Forecast, 2020 – 2028
10.2.10.5.5. Latin
America
10.2.10.5.5.1. Market
Estimation, 2015 – 2019
10.2.10.5.5.2. Market
Forecast, 2020 – 2028
10.2.11. Specialized
SOP’s
10.2.11.1. Definition
10.2.11.2. Market
Estimation and Penetration, 2015 – 2019
10.2.11.3. Market
Forecast, 2020 – 2028
10.2.11.4. Compound
Annual Growth Rate (CAGR)
10.2.11.5. Regional
Bifurcation
10.2.11.5.1. North
America
10.2.11.5.1.1. Market
Estimation, 2015 – 2019
10.2.11.5.1.2. Market
Forecast, 2020 – 2028
10.2.11.5.2. Europe
10.2.11.5.2.1. Market
Estimation, 2015 – 2019
10.2.11.5.2.2. Market
Forecast, 2020 – 2028
10.2.11.5.3. Asia
Pacific
10.2.11.5.3.1. Market
Estimation, 2015 – 2019
10.2.11.5.3.2. Market
Forecast, 2020 – 2028
10.2.11.5.4. Middle
East and Africa
10.2.11.5.4.1. Market
Estimation, 2015 – 2019
10.2.11.5.4.2. Market
Forecast, 2020 – 2028
10.2.11.5.5. Latin
America
10.2.11.5.5.1. Market
Estimation, 2015 – 2019
10.2.11.5.5.2. Market
Forecast, 2020 – 2028
10.2.12. Others
10.2.12.1. Definition
10.2.12.2. Market
Estimation and Penetration, 2015 – 2019
10.2.12.3. Market
Forecast, 2020 – 2028
10.2.12.4. Compound
Annual Growth Rate (CAGR)
10.2.12.5. Regional
Bifurcation
10.2.12.5.1. North
America
10.2.12.5.1.1. Market
Estimation, 2015 – 2019
10.2.12.5.1.2. Market
Forecast, 2020 – 2028
10.2.12.5.2. Europe
10.2.12.5.2.1. Market
Estimation, 2015 – 2019
10.2.12.5.2.2. Market
Forecast, 2020 – 2028
10.2.12.5.3. Asia
Pacific
10.2.12.5.3.1. Market
Estimation, 2015 – 2019
10.2.12.5.3.2. Market
Forecast, 2020 – 2028
10.2.12.5.4. Middle
East and Africa
10.2.12.5.4.1. Market
Estimation, 2015 – 2019
10.2.12.5.4.2. Market
Forecast, 2020 – 2028
10.2.12.5.5. Latin
America
10.2.12.5.5.1. Market
Estimation, 2015 – 2019
10.2.12.5.5.2. Market
Forecast, 2020 – 2028
10.3. Key
Segment for Channeling Investments
10.3.1. By
Services
11. Global
Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 – 2028
11.1. Overview
11.2. Global
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By Application
11.2.1. Regional
distributors
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 – 2019
11.2.1.3. Market
Forecast, 2020 – 2028
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 – 2019
11.2.1.5.1.2. Market
Forecast, 2020 – 2028
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2019
11.2.1.5.2.2. Market
Forecast, 2020 – 2028
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2019
11.2.1.5.3.2. Market
Forecast, 2020 – 2028
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2019
11.2.1.5.4.2. Market
Forecast, 2020 – 2028
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 – 2019
11.2.1.5.5.2. Market
Forecast, 2020 – 2028
11.2.2. Multi-nationals
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 – 2019
11.2.2.3. Market
Forecast, 2020 – 2028
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 – 2019
11.2.2.5.1.2. Market
Forecast, 2020 – 2028
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2019
11.2.2.5.2.2. Market
Forecast, 2020 – 2028
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2019
11.2.2.5.3.2. Market
Forecast, 2020 – 2028
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2019
11.2.2.5.4.2. Market
Forecast, 2020 – 2028
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 – 2019
11.2.2.5.5.2. Market
Forecast, 2020 – 2028
11.2.3. Others
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 – 2019
11.2.3.3. Market
Forecast, 2020 – 2028
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 – 2019
11.2.3.5.1.2. Market
Forecast, 2020 – 2028
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 – 2019
11.2.3.5.2.2. Market
Forecast, 2020 – 2028
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 – 2019
11.2.3.5.3.2. Market
Forecast, 2020 – 2028
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 – 2019
11.2.3.5.4.2. Market
Forecast, 2020 – 2028
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 – 2019
11.2.3.5.5.2. Market
Forecast, 2020 – 2028
11.3. Key
Segment for Channeling Investments
11.3.1. By
Application
12. Global
Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 – 2028
12.1. Overview
12.2. Global
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
12.2.1. Electrical
refrigeration
12.2.1.1. Definition
12.2.1.2. Market
Estimation and Penetration, 2015 – 2019
12.2.1.3. Market
Forecast, 2020 – 2028
12.2.1.4. Compound
Annual Growth Rate (CAGR)
12.2.1.5. Regional
Bifurcation
12.2.1.5.1. North
America
12.2.1.5.1.1. Market
Estimation, 2015 – 2019
12.2.1.5.1.2. Market
Forecast, 2020 – 2028
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 – 2019
12.2.1.5.2.2. Market
Forecast, 2020 – 2028
12.2.1.5.3. Asia
Pacific
12.2.1.5.3.1. Market
Estimation, 2015 – 2019
12.2.1.5.3.2. Market
Forecast, 2020 – 2028
12.2.1.5.4. Middle
East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 – 2019
12.2.1.5.4.2. Market
Forecast, 2020 – 2028
12.2.1.5.5. Latin
America
12.2.1.5.5.1. Market
Estimation, 2015 – 2019
12.2.1.5.5.2. Market
Forecast, 2020 – 2028
12.2.2. Dry Ice
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2015 – 2019
12.2.2.3. Market
Forecast, 2020 – 2028
12.2.2.4. Compound
Annual Growth Rate (CAGR)
12.2.2.5. Regional
Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2015 – 2019
12.2.2.5.1.2. Market
Forecast, 2020 – 2028
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 – 2019
12.2.2.5.2.2. Market
Forecast, 2020 – 2028
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2015 – 2019
12.2.2.5.3.2. Market
Forecast, 2020 – 2028
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 – 2019
12.2.2.5.4.2. Market
Forecast, 2020 – 2028
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2015 – 2019
12.2.2.5.5.2. Market
Forecast, 2020 – 2028
12.2.3. Gel
Packs
12.2.3.1. Definition
12.2.3.2. Market
Estimation and Penetration, 2015 – 2019
12.2.3.3. Market
Forecast, 2020 – 2028
12.2.3.4. Compound
Annual Growth Rate (CAGR)
12.2.3.5. Regional
Bifurcation
12.2.3.5.1. North
America
12.2.3.5.1.1. Market
Estimation, 2015 – 2019
12.2.3.5.1.2. Market
Forecast, 2020 – 2028
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 – 2019
12.2.3.5.2.2. Market
Forecast, 2020 – 2028
12.2.3.5.3. Asia
Pacific
12.2.3.5.3.1. Market
Estimation, 2015 – 2019
12.2.3.5.3.2. Market
Forecast, 2020 – 2028
12.2.3.5.4. Middle
East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 – 2019
12.2.3.5.4.2. Market
Forecast, 2020 – 2028
12.2.3.5.5. Latin
America
12.2.3.5.5.1. Market
Estimation, 2015 – 2019
12.2.3.5.5.2. Market
Forecast, 2020 – 2028
12.2.4. Liquid
nitrogen
12.2.4.1. Definition
12.2.4.2. Market
Estimation and Penetration, 2015 – 2019
12.2.4.3. Market
Forecast, 2020 – 2028
12.2.4.4. Compound
Annual Growth Rate (CAGR)
12.2.4.5. Regional
Bifurcation
12.2.4.5.1. North
America
12.2.4.5.1.1. Market
Estimation, 2015 – 2019
12.2.4.5.1.2. Market
Forecast, 2020 – 2028
12.2.4.5.2. Europe
12.2.4.5.2.1. Market
Estimation, 2015 – 2019
12.2.4.5.2.2. Market
Forecast, 2020 – 2028
12.2.4.5.3. Asia
Pacific
12.2.4.5.3.1. Market
Estimation, 2015 – 2019
12.2.4.5.3.2. Market
Forecast, 2020 – 2028
12.2.4.5.4. Middle
East and Africa
12.2.4.5.4.1. Market
Estimation, 2015 – 2019
12.2.4.5.4.2. Market
Forecast, 2020 – 2028
12.2.4.5.5. Latin
America
12.2.4.5.5.1. Market
Estimation, 2015 – 2019
12.2.4.5.5.2. Market
Forecast, 2020 – 2028
12.2.5. Others
12.2.5.1. Definition
12.2.5.2. Market
Estimation and Penetration, 2015 – 2019
12.2.5.3. Market
Forecast, 2020 – 2028
12.2.5.4. Compound
Annual Growth Rate (CAGR)
12.2.5.5. Regional
Bifurcation
12.2.5.5.1. North
America
12.2.5.5.1.1. Market
Estimation, 2015 – 2019
12.2.5.5.1.2. Market
Forecast, 2020 – 2028
12.2.5.5.2. Europe
12.2.5.5.2.1. Market
Estimation, 2015 – 2019
12.2.5.5.2.2. Market
Forecast, 2020 – 2028
12.2.5.5.3. Asia
Pacific
12.2.5.5.3.1. Market
Estimation, 2015 – 2019
12.2.5.5.3.2. Market
Forecast, 2020 – 2028
12.2.5.5.4. Middle
East and Africa
12.2.5.5.4.1. Market
Estimation, 2015 – 2019
12.2.5.5.4.2. Market
Forecast, 2020 – 2028
12.2.5.5.5. Latin
America
12.2.5.5.5.1. Market
Estimation, 2015 – 2019
12.2.5.5.5.2. Market
Forecast, 2020 – 2028
12.3. Key
Segment for Channeling Investments
12.3.1. By
Storage Techniques
13. Global
Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 – 2028
13.1. Overview
13.2. Global
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
13.2.1. Hospitals/Clinics
13.2.1.1. Definition
13.2.1.2. Market
Estimation and Penetration, 2015 – 2019
13.2.1.3. Market
Forecast, 2020 – 2028
13.2.1.4. Compound
Annual Growth Rate (CAGR)
13.2.1.5. Regional
Bifurcation
13.2.1.5.1. North
America
13.2.1.5.1.1. Market
Estimation, 2015 – 2019
13.2.1.5.1.2. Market
Forecast, 2020 – 2028
13.2.1.5.2. Europe
13.2.1.5.2.1. Market
Estimation, 2015 – 2019
13.2.1.5.2.2. Market
Forecast, 2020 – 2028
13.2.1.5.3. Asia
Pacific
13.2.1.5.3.1. Market
Estimation, 2015 – 2019
13.2.1.5.3.2. Market
Forecast, 2020 – 2028
13.2.1.5.4. Middle
East and Africa
13.2.1.5.4.1. Market
Estimation, 2015 – 2019
13.2.1.5.4.2. Market
Forecast, 2020 – 2028
13.2.1.5.5. Latin
America
13.2.1.5.5.1. Market
Estimation, 2015 – 2019
13.2.1.5.5.2. Market
Forecast, 2020 – 2028
13.2.2. Research
Laboratories
13.2.2.1. Definition
13.2.2.2. Market
Estimation and Penetration, 2015 – 2019
13.2.2.3. Market
Forecast, 2020 – 2028
13.2.2.4. Compound
Annual Growth Rate (CAGR)
13.2.2.5. Regional
Bifurcation
13.2.2.5.1. North
America
13.2.2.5.1.1. Market
Estimation, 2015 – 2019
13.2.2.5.1.2. Market
Forecast, 2020 – 2028
13.2.2.5.2. Europe
13.2.2.5.2.1. Market
Estimation, 2015 – 2019
13.2.2.5.2.2. Market
Forecast, 2020 – 2028
13.2.2.5.3. Asia
Pacific
13.2.2.5.3.1. Market
Estimation, 2015 – 2019
13.2.2.5.3.2. Market
Forecast, 2020 – 2028
13.2.2.5.4. Middle
East and Africa
13.2.2.5.4.1. Market
Estimation, 2015 – 2019
13.2.2.5.4.2. Market
Forecast, 2020 – 2028
13.2.2.5.5. Latin
America
13.2.2.5.5.1. Market
Estimation, 2015 – 2019
13.2.2.5.5.2. Market
Forecast, 2020 – 2028
13.2.3. Pharmacies
13.2.3.1. Definition
13.2.3.2. Market
Estimation and Penetration, 2015 – 2019
13.2.3.3. Market
Forecast, 2020 – 2028
13.2.3.4. Compound
Annual Growth Rate (CAGR)
13.2.3.5. Regional
Bifurcation
13.2.3.5.1. North
America
13.2.3.5.1.1. Market
Estimation, 2015 – 2019
13.2.3.5.1.2. Market
Forecast, 2020 – 2028
13.2.3.5.2. Europe
13.2.3.5.2.1. Market
Estimation, 2015 – 2019
13.2.3.5.2.2. Market
Forecast, 2020 – 2028
13.2.3.5.3. Asia
Pacific
13.2.3.5.3.1. Market
Estimation, 2015 – 2019
13.2.3.5.3.2. Market
Forecast, 2020 – 2028
13.2.3.5.4. Middle
East and Africa
13.2.3.5.4.1. Market
Estimation, 2015 – 2019
13.2.3.5.4.2. Market
Forecast, 2020 – 2028
13.2.3.5.5. Latin
America
13.2.3.5.5.1. Market
Estimation, 2015 – 2019
13.2.3.5.5.2. Market
Forecast, 2020 – 2028
13.2.4. Ambulatory
Care Units
13.2.4.1. Definition
13.2.4.2. Market
Estimation and Penetration, 2015 – 2019
13.2.4.3. Market
Forecast, 2020 – 2028
13.2.4.4. Compound
Annual Growth Rate (CAGR)
13.2.4.5. Regional
Bifurcation
13.2.4.5.1. North
America
13.2.4.5.1.1. Market
Estimation, 2015 – 2019
13.2.4.5.1.2. Market
Forecast, 2020 – 2028
13.2.4.5.2. Europe
13.2.4.5.2.1. Market
Estimation, 2015 – 2019
13.2.4.5.2.2. Market
Forecast, 2020 – 2028
13.2.4.5.3. Asia
Pacific
13.2.4.5.3.1. Market
Estimation, 2015 – 2019
13.2.4.5.3.2. Market
Forecast, 2020 – 2028
13.2.4.5.4. Middle
East and Africa
13.2.4.5.4.1. Market
Estimation, 2015 – 2019
13.2.4.5.4.2. Market
Forecast, 2020 – 2028
13.2.4.5.5. Latin
America
13.2.4.5.5.1. Market
Estimation, 2015 – 2019
13.2.4.5.5.2. Market
Forecast, 2020 – 2028
13.2.5. Others
13.2.5.1. Definition
13.2.5.2. Market
Estimation and Penetration, 2015 – 2019
13.2.5.3. Market
Forecast, 2020 – 2028
13.2.5.4. Compound
Annual Growth Rate (CAGR)
13.2.5.5. Regional
Bifurcation
13.2.5.5.1. North
America
13.2.5.5.1.1. Market
Estimation, 2015 – 2019
13.2.5.5.1.2. Market
Forecast, 2020 – 2028
13.2.5.5.2. Europe
13.2.5.5.2.1. Market
Estimation, 2015 – 2019
13.2.5.5.2.2. Market
Forecast, 2020 – 2028
13.2.5.5.3. Asia
Pacific
13.2.5.5.3.1. Market
Estimation, 2015 – 2019
13.2.5.5.3.2. Market
Forecast, 2020 – 2028
13.2.5.5.4. Middle
East and Africa
13.2.5.5.4.1. Market
Estimation, 2015 – 2019
13.2.5.5.4.2. Market
Forecast, 2020 – 2028
13.2.5.5.5. Latin
America
13.2.5.5.5.1. Market
Estimation, 2015 – 2019
13.2.5.5.5.2. Market
Forecast, 2020 – 2028
13.3. Key
Segment for Channeling Investments
13.3.1. By End
Users
14. North
America Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 -
2028
14.1. Overview
14.1.1. North
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn)
14.2. North
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Product
14.2.1. Vaccines
14.2.2. Pharmaceuticals
14.2.2.1. High
Value Specialities
14.2.2.2. Biosimilars
14.2.2.3. Small
molecule innovative drugs
14.2.2.4. Generic
14.2.2.5. OTC
Products
14.2.2.6. Others
14.2.3. APIs
14.2.4. Controlled
Drugs
14.2.5. Biopharmaceuticals
14.2.6. Clinical
Trials
14.2.7. Others (First
Aid etc.)
14.3. North
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Temperature
14.3.1. 15-25°C
controlled
14.3.2. Refrigerated
2-8°C
14.3.3. Frozen
-24°C
14.3.4. Cryogenic
-170°C
14.3.5. Others
14.4. North
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Services
14.4.1. End-to-End
Cold Chain Distribution
14.4.2. Time
and Temperature-Sensitive Shipments
14.4.3. Temperature-Controlled
GDP Vehicles
14.4.4. Packaging
14.4.5. Warehousing
14.4.6. Transportation
14.4.7. Container
Solutions
14.4.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
14.4.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
14.4.10. GDP
Compliant Distribution
14.4.11. Specialized
SOP’s
14.4.12. Others
14.5. North
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Application
14.5.1. Regional
distributors
14.5.2. Multi-nationals
14.5.3. Others
14.6. North
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Storage Techniques
14.6.1. Electrical
refrigeration
14.6.2. Dry Ice
14.6.3. Gel
Packs
14.6.4. Liquid
nitrogen
14.6.5. Others
14.7. North
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.1. Hospitals/Clinics
14.7.2. Research
Laboratories
14.7.3. Pharmacies
14.7.4. Ambulatory
Care Units
14.7.5. Others
14.8. North
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Country
14.8.1. U.S
14.8.1.1. U.S
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
14.8.1.1.1. Vaccines
14.8.1.1.2. Pharmaceuticals
14.8.1.1.2.1. High
Value Specialities
14.8.1.1.2.2. Biosimilars
14.8.1.1.2.3. Small
molecule innovative drugs
14.8.1.1.2.4. Generic
14.8.1.1.2.5. OTC
Products
14.8.1.1.2.6. Others
14.8.1.1.3. APIs
14.8.1.1.4. Controlled
Drugs
14.8.1.1.5. Biopharmaceuticals
14.8.1.1.6. Clinical
Trials
14.8.1.1.7. Others
(First Aid etc.)
14.8.1.2. U.S Healthcare
Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By Temperature
14.8.1.2.1. 15-25°C
controlled
14.8.1.2.2. Refrigerated
2-8°C
14.8.1.2.3. Frozen
-24°C
14.8.1.2.4. Cryogenic
-170°C
14.8.1.2.5. Others
14.8.1.3. U.S
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
14.8.1.3.1. End-to-End
Cold Chain Distribution
14.8.1.3.2. Time
and Temperature-Sensitive Shipments
14.8.1.3.3. Temperature-Controlled
GDP Vehicles
14.8.1.3.4. Packaging
14.8.1.3.5. Warehousing
14.8.1.3.6. Transportation
14.8.1.3.7. Container
Solutions
14.8.1.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
14.8.1.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
14.8.1.3.10. GDP
Compliant Distribution
14.8.1.3.11. Specialized
SOP’s
14.8.1.3.12. Others
14.8.1.4. U.S
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
14.8.1.4.1. Regional
distributors
14.8.1.4.2. Multi-nationals
14.8.1.4.3. Others
14.8.1.5. U.S
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
14.8.1.5.1. Electrical
refrigeration
14.8.1.5.2. Dry
Ice
14.8.1.5.3. Gel
Packs
14.8.1.5.4. Liquid
nitrogen
14.8.1.5.5. Others
14.8.1.6. U.S
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
14.8.1.6.1. Hospitals/Clinics
14.8.1.6.2. Research
Laboratories
14.8.1.6.3. Pharmacies
14.8.1.6.4. Ambulatory
Care Units
14.8.1.6.5. Others
14.8.2. Canada
14.8.2.1. Canada
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
14.8.2.1.1. Vaccines
14.8.2.1.2. Pharmaceuticals
14.8.2.1.2.1. High
Value Specialities
14.8.2.1.2.2. Biosimilars
14.8.2.1.2.3. Small
molecule innovative drugs
14.8.2.1.2.4. Generic
14.8.2.1.2.5. OTC
Products
14.8.2.1.2.6. Others
14.8.2.1.3. APIs
14.8.2.1.4. Controlled
Drugs
14.8.2.1.5. Biopharmaceuticals
14.8.2.1.6. Clinical
Trials
14.8.2.1.7. Others
(First Aid etc.)
14.8.2.2. Canada
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
14.8.2.2.1. 15-25°C
controlled
14.8.2.2.2. Refrigerated
2-8°C
14.8.2.2.3. Frozen
-24°C
14.8.2.2.4. Cryogenic
-170°C
14.8.2.2.5. Others
14.8.2.3. Canada
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
14.8.2.3.1. End-to-End
Cold Chain Distribution
14.8.2.3.2. Time
and Temperature-Sensitive Shipments
14.8.2.3.3. Temperature-Controlled
GDP Vehicles
14.8.2.3.4. Packaging
14.8.2.3.5. Warehousing
14.8.2.3.6. Transportation
14.8.2.3.7. Container
Solutions
14.8.2.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
14.8.2.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
14.8.2.3.10. GDP
Compliant Distribution
14.8.2.3.11. Specialized
SOP’s
14.8.2.3.12. Others
14.8.2.4. Canada
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
14.8.2.4.1. Regional
distributors
14.8.2.4.2. Multi-nationals
14.8.2.4.3. Others
14.8.2.5. Canada
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
14.8.2.5.1. Electrical
refrigeration
14.8.2.5.2. Dry
Ice
14.8.2.5.3. Gel
Packs
14.8.2.5.4. Liquid
nitrogen
14.8.2.5.5. Others
14.8.2.6. Canada
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
14.8.2.6.1. Hospitals/Clinics
14.8.2.6.2. Research
Laboratories
14.8.2.6.3. Pharmacies
14.8.2.6.4. Ambulatory
Care Units
14.8.2.6.5. Others
14.8.3. Mexico
14.8.3.1. Mexico
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
14.8.3.1.1. Vaccines
14.8.3.1.2. Pharmaceuticals
14.8.3.1.2.1. High
Value Specialities
14.8.3.1.2.2. Biosimilars
14.8.3.1.2.3. Small
molecule innovative drugs
14.8.3.1.2.4. Generic
14.8.3.1.2.5. OTC
Products
14.8.3.1.2.6. Others
14.8.3.1.3. APIs
14.8.3.1.4. Controlled
Drugs
14.8.3.1.5. Biopharmaceuticals
14.8.3.1.6. Clinical
Trials
14.8.3.1.7. Others
(First Aid etc.)
14.8.3.2. Mexico
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
14.8.3.2.1. 15-25°C
controlled
14.8.3.2.2. Refrigerated
2-8°C
14.8.3.2.3. Frozen
-24°C
14.8.3.2.4. Cryogenic
-170°C
14.8.3.2.5. Others
14.8.3.3. Mexico
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
14.8.3.3.1. End-to-End
Cold Chain Distribution
14.8.3.3.2. Time
and Temperature-Sensitive Shipments
14.8.3.3.3. Temperature-Controlled
GDP Vehicles
14.8.3.3.4. Packaging
14.8.3.3.5. Warehousing
14.8.3.3.6. Transportation
14.8.3.3.7. Container
Solutions
14.8.3.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
14.8.3.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
14.8.3.3.10. GDP
Compliant Distribution
14.8.3.3.11. Specialized
SOP’s
14.8.3.3.12. Others
14.8.3.4. Mexico
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
14.8.3.4.1. Regional
distributors
14.8.3.4.2. Multi-nationals
14.8.3.4.3. Others
14.8.3.5. Mexico
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
14.8.3.5.1. Electrical
refrigeration
14.8.3.5.2. Dry
Ice
14.8.3.5.3. Gel
Packs
14.8.3.5.4. Liquid
nitrogen
14.8.3.5.5. Others
14.8.3.6. Mexico
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
14.8.3.6.1. Hospitals/Clinics
14.8.3.6.2. Research
Laboratories
14.8.3.6.3. Pharmacies
14.8.3.6.4. Ambulatory
Care Units
14.8.3.6.5. Others
14.8.4. Rest of
North America
14.8.4.1. Rest
of North America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Product
14.8.4.1.1. Vaccines
14.8.4.1.2. Pharmaceuticals
14.8.4.1.2.1. High
Value Specialities
14.8.4.1.2.2. Biosimilars
14.8.4.1.2.3. Small
molecule innovative drugs
14.8.4.1.2.4. Generic
14.8.4.1.2.5. OTC
Products
14.8.4.1.2.6. Others
14.8.4.1.3. APIs
14.8.4.1.4. Controlled
Drugs
14.8.4.1.5. Biopharmaceuticals
14.8.4.1.6. Clinical
Trials
14.8.4.1.7. Others
(First Aid etc.)
14.8.4.2. Rest
of North America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Temperature
14.8.4.2.1. 15-25°C
controlled
14.8.4.2.2. Refrigerated
2-8°C
14.8.4.2.3. Frozen
-24°C
14.8.4.2.4. Cryogenic
-170°C
14.8.4.2.5. Others
14.8.4.3. Rest
of North America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Services
14.8.4.3.1. End-to-End
Cold Chain Distribution
14.8.4.3.2. Time
and Temperature-Sensitive Shipments
14.8.4.3.3. Temperature-Controlled
GDP Vehicles
14.8.4.3.4. Packaging
14.8.4.3.5. Warehousing
14.8.4.3.6. Transportation
14.8.4.3.7. Container
Solutions
14.8.4.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
14.8.4.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
14.8.4.3.10. GDP
Compliant Distribution
14.8.4.3.11. Specialized
SOP’s
14.8.4.3.12. Others
14.8.4.4. Rest
of North America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Application
14.8.4.4.1. Regional
distributors
14.8.4.4.2. Multi-nationals
14.8.4.4.3. Others
14.8.4.5. Rest
of North America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Storage Techniques
14.8.4.5.1. Electrical
refrigeration
14.8.4.5.2. Dry
Ice
14.8.4.5.3. Gel
Packs
14.8.4.5.4. Liquid
nitrogen
14.8.4.5.5. Others
14.8.4.6. Rest
of North America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By End Users
14.8.4.6.1. Hospitals/Clinics
14.8.4.6.2. Research
Laboratories
14.8.4.6.3. Pharmacies
14.8.4.6.4. Ambulatory
Care Units
14.8.4.6.5. Others
14.9. Key
Segment for Channeling Investments
14.9.1. By
Country
14.9.2. By Product
14.9.3. By
Temperature
14.9.4. By
Services
14.9.5. By
Application
14.9.6. By
Storage Techniques
14.9.7. By End
Users
15. Europe
Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Europe
Healthcare Cold Chain Logistics Market Revenue (US$ Mn)
15.2. Europe
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
15.2.1. Vaccines
15.2.2. Pharmaceuticals
15.2.2.1. High
Value Specialities
15.2.2.2. Biosimilars
15.2.2.3. Small
molecule innovative drugs
15.2.2.4. Generic
15.2.2.5. OTC
Products
15.2.2.6. Others
15.2.3. APIs
15.2.4. Controlled
Drugs
15.2.5. Biopharmaceuticals
15.2.6. Clinical
Trials
15.2.7. Others
(First Aid etc.)
15.3. Europe
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
15.3.1. 15-25°C
controlled
15.3.2. Refrigerated
2-8°C
15.3.3. Frozen
-24°C
15.3.4. Cryogenic
-170°C
15.3.5. Others
15.4. Europe
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
15.4.1. End-to-End
Cold Chain Distribution
15.4.2. Time
and Temperature-Sensitive Shipments
15.4.3. Temperature-Controlled
GDP Vehicles
15.4.4. Packaging
15.4.5. Warehousing
15.4.6. Transportation
15.4.7. Container
Solutions
15.4.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.4.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.4.10. GDP
Compliant Distribution
15.4.11. Specialized
SOP’s
15.4.12. Others
15.5. Europe
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.1. Regional
distributors
15.5.2. Multi-nationals
15.5.3. Others
15.6. Europe
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
15.6.1. Electrical
refrigeration
15.6.2. Dry Ice
15.6.3. Gel
Packs
15.6.4. Liquid
nitrogen
15.6.5. Others
15.7. Europe
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
15.7.1. Hospitals/Clinics
15.7.2. Research
Laboratories
15.7.3. Pharmacies
15.7.4. Ambulatory
Care Units
15.7.5. Others
15.8. Europe
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Country
15.8.1. France
15.8.1.1. France
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By Product
15.8.1.1.1. Vaccines
15.8.1.1.2. Pharmaceuticals
15.8.1.1.2.1. High
Value Specialities
15.8.1.1.2.2. Biosimilars
15.8.1.1.2.3. Small
molecule innovative drugs
15.8.1.1.2.4. Generic
15.8.1.1.2.5. OTC
Products
15.8.1.1.2.6. Others
15.8.1.1.3. APIs
15.8.1.1.4. Controlled
Drugs
15.8.1.1.5. Biopharmaceuticals
15.8.1.1.6. Clinical
Trials
15.8.1.1.7. Others
(First Aid etc.)
15.8.1.2. France
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
15.8.1.2.1. 15-25°C
controlled
15.8.1.2.2. Refrigerated
2-8°C
15.8.1.2.3. Frozen
-24°C
15.8.1.2.4. Cryogenic
-170°C
15.8.1.2.5. Others
15.8.1.3. France
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
15.8.1.3.1. End-to-End
Cold Chain Distribution
15.8.1.3.2. Time
and Temperature-Sensitive Shipments
15.8.1.3.3. Temperature-Controlled
GDP Vehicles
15.8.1.3.4. Packaging
15.8.1.3.5. Warehousing
15.8.1.3.6. Transportation
15.8.1.3.7. Container
Solutions
15.8.1.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.8.1.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.8.1.3.10. GDP
Compliant Distribution
15.8.1.3.11. Specialized
SOP’s
15.8.1.3.12. Others
15.8.1.4. France
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.1.4.1. Regional
distributors
15.8.1.4.2. Multi-nationals
15.8.1.4.3. Others
15.8.1.5. France
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
15.8.1.5.1. Electrical
refrigeration
15.8.1.5.2. Dry
Ice
15.8.1.5.3. Gel
Packs
15.8.1.5.4. Liquid
nitrogen
15.8.1.5.5. Others
15.8.1.6. France
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
15.8.1.6.1. Hospitals/Clinics
15.8.1.6.2. Research
Laboratories
15.8.1.6.3. Pharmacies
15.8.1.6.4. Ambulatory
Care Units
15.8.1.6.5. Others
15.8.2. The UK
15.8.2.1. The
UK Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
15.8.2.1.1. Vaccines
15.8.2.1.2. Pharmaceuticals
15.8.2.1.2.1. High
Value Specialities
15.8.2.1.2.2. Biosimilars
15.8.2.1.2.3. Small
molecule innovative drugs
15.8.2.1.2.4. Generic
15.8.2.1.2.5. OTC
Products
15.8.2.1.2.6. Others
15.8.2.1.3. APIs
15.8.2.1.4. Controlled
Drugs
15.8.2.1.5. Biopharmaceuticals
15.8.2.1.6. Clinical
Trials
15.8.2.1.7. Others
(First Aid etc.)
15.8.2.2. The
UK Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
15.8.2.2.1. 15-25°C
controlled
15.8.2.2.2. Refrigerated
2-8°C
15.8.2.2.3. Frozen
-24°C
15.8.2.2.4. Cryogenic
-170°C
15.8.2.2.5. Others
15.8.2.3. The
UK Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
15.8.2.3.1. End-to-End
Cold Chain Distribution
15.8.2.3.2. Time
and Temperature-Sensitive Shipments
15.8.2.3.3. Temperature-Controlled
GDP Vehicles
15.8.2.3.4. Packaging
15.8.2.3.5. Warehousing
15.8.2.3.6. Transportation
15.8.2.3.7. Container
Solutions
15.8.2.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.8.2.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.8.2.3.10. GDP
Compliant Distribution
15.8.2.3.11. Specialized
SOP’s
15.8.2.3.12. Others
15.8.2.4. The
UK Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.2.4.1. Regional
distributors
15.8.2.4.2. Multi-nationals
15.8.2.4.3. Others
15.8.2.5. The
UK Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
15.8.2.5.1. Electrical
refrigeration
15.8.2.5.2. Dry
Ice
15.8.2.5.3. Gel
Packs
15.8.2.5.4. Liquid
nitrogen
15.8.2.5.5. Others
15.8.2.6. The
UK Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
End Users
15.8.2.6.1. Hospitals/Clinics
15.8.2.6.2. Research
Laboratories
15.8.2.6.3. Pharmacies
15.8.2.6.4. Ambulatory
Care Units
15.8.2.6.5. Others
15.8.3. Spain
15.8.3.1. Spain
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
15.8.3.1.1. Vaccines
15.8.3.1.2. Pharmaceuticals
15.8.3.1.2.1. High
Value Specialities
15.8.3.1.2.2. Biosimilars
15.8.3.1.2.3. Small
molecule innovative drugs
15.8.3.1.2.4. Generic
15.8.3.1.2.5. OTC
Products
15.8.3.1.2.6. Others
15.8.3.1.3. APIs
15.8.3.1.4. Controlled
Drugs
15.8.3.1.5. Biopharmaceuticals
15.8.3.1.6. Clinical
Trials
15.8.3.1.7. Others
(First Aid etc.)
15.8.3.2. Spain
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By Temperature
15.8.3.2.1. 15-25°C
controlled
15.8.3.2.2. Refrigerated
2-8°C
15.8.3.2.3. Frozen
-24°C
15.8.3.2.4. Cryogenic
-170°C
15.8.3.2.5. Others
15.8.3.3. Spain
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
15.8.3.3.1. End-to-End
Cold Chain Distribution
15.8.3.3.2. Time
and Temperature-Sensitive Shipments
15.8.3.3.3. Temperature-Controlled
GDP Vehicles
15.8.3.3.4. Packaging
15.8.3.3.5. Warehousing
15.8.3.3.6. Transportation
15.8.3.3.7. Container
Solutions
15.8.3.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.8.3.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.8.3.3.10. GDP
Compliant Distribution
15.8.3.3.11. Specialized
SOP’s
15.8.3.3.12. Others
15.8.3.4. Spain
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.3.4.1. Regional
distributors
15.8.3.4.2. Multi-nationals
15.8.3.4.3. Others
15.8.3.5. Spain
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
15.8.3.5.1. Electrical
refrigeration
15.8.3.5.2. Dry
Ice
15.8.3.5.3. Gel
Packs
15.8.3.5.4. Liquid
nitrogen
15.8.3.5.5. Others
15.8.3.6. Spain
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
15.8.3.6.1. Hospitals/Clinics
15.8.3.6.2. Research
Laboratories
15.8.3.6.3. Pharmacies
15.8.3.6.4. Ambulatory
Care Units
15.8.3.6.5. Others
15.8.4. Germany
15.8.4.1. Germany
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
15.8.4.1.1. Vaccines
15.8.4.1.2. Pharmaceuticals
15.8.4.1.2.1. High
Value Specialities
15.8.4.1.2.2. Biosimilars
15.8.4.1.2.3. Small
molecule innovative drugs
15.8.4.1.2.4. Generic
15.8.4.1.2.5. OTC
Products
15.8.4.1.2.6. Others
15.8.4.1.3. APIs
15.8.4.1.4. Controlled
Drugs
15.8.4.1.5. Biopharmaceuticals
15.8.4.1.6. Clinical
Trials
15.8.4.1.7. Others
(First Aid etc.)
15.8.4.2. Germany
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
15.8.4.2.1. 15-25°C
controlled
15.8.4.2.2. Refrigerated
2-8°C
15.8.4.2.3. Frozen
-24°C
15.8.4.2.4. Cryogenic
-170°C
15.8.4.2.5. Others
15.8.4.3. Germany
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
15.8.4.3.1. End-to-End
Cold Chain Distribution
15.8.4.3.2. Time
and Temperature-Sensitive Shipments
15.8.4.3.3. Temperature-Controlled
GDP Vehicles
15.8.4.3.4. Packaging
15.8.4.3.5. Warehousing
15.8.4.3.6. Transportation
15.8.4.3.7. Container
Solutions
15.8.4.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.8.4.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.8.4.3.10. GDP
Compliant Distribution
15.8.4.3.11. Specialized
SOP’s
15.8.4.3.12. Others
15.8.4.4. Germany
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.4.4.1. Regional
distributors
15.8.4.4.2. Multi-nationals
15.8.4.4.3. Others
15.8.4.5. Germany
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
15.8.4.5.1. Electrical
refrigeration
15.8.4.5.2. Dry
Ice
15.8.4.5.3. Gel
Packs
15.8.4.5.4. Liquid
nitrogen
15.8.4.5.5. Others
15.8.4.6. Germany
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
15.8.4.6.1. Hospitals/Clinics
15.8.4.6.2. Research
Laboratories
15.8.4.6.3. Pharmacies
15.8.4.6.4. Ambulatory
Care Units
15.8.4.6.5. Others
15.8.5. Italy
15.8.5.1. Italy
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
15.8.5.1.1. Vaccines
15.8.5.1.2. Pharmaceuticals
15.8.5.1.2.1. High
Value Specialities
15.8.5.1.2.2. Biosimilars
15.8.5.1.2.3. Small
molecule innovative drugs
15.8.5.1.2.4. Generic
15.8.5.1.2.5. OTC
Products
15.8.5.1.2.6. Others
15.8.5.1.3. APIs
15.8.5.1.4. Controlled
Drugs
15.8.5.1.5. Biopharmaceuticals
15.8.5.1.6. Clinical
Trials
15.8.5.1.7. Others
(First Aid etc.)
15.8.5.2. Italy
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
15.8.5.2.1. 15-25°C
controlled
15.8.5.2.2. Refrigerated
2-8°C
15.8.5.2.3. Frozen
-24°C
15.8.5.2.4. Cryogenic
-170°C
15.8.5.2.5. Others
15.8.5.3. Italy
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
15.8.5.3.1. End-to-End
Cold Chain Distribution
15.8.5.3.2. Time
and Temperature-Sensitive Shipments
15.8.5.3.3. Temperature-Controlled
GDP Vehicles
15.8.5.3.4. Packaging
15.8.5.3.5. Warehousing
15.8.5.3.6. Transportation
15.8.5.3.7. Container
Solutions
15.8.5.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.8.5.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.8.5.3.10. GDP
Compliant Distribution
15.8.5.3.11. Specialized
SOP’s
15.8.5.3.12. Others
15.8.5.4. Italy
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.5.4.1. Regional
distributors
15.8.5.4.2. Multi-nationals
15.8.5.4.3. Others
15.8.5.5. Italy
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
15.8.5.5.1. Electrical
refrigeration
15.8.5.5.2. Dry
Ice
15.8.5.5.3. Gel
Packs
15.8.5.5.4. Liquid
nitrogen
15.8.5.5.5. Others
15.8.5.6. Italy
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
15.8.5.6.1. Hospitals/Clinics
15.8.5.6.2. Research
Laboratories
15.8.5.6.3. Pharmacies
15.8.5.6.4. Ambulatory
Care Units
15.8.5.6.5. Others
15.8.6. Nordic
Countries
15.8.6.1. Nordic
Countries Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Product
15.8.6.1.1. Vaccines
15.8.6.1.2. Pharmaceuticals
15.8.6.1.2.1. High
Value Specialities
15.8.6.1.2.2. Biosimilars
15.8.6.1.2.3. Small
molecule innovative drugs
15.8.6.1.2.4. Generic
15.8.6.1.2.5. OTC
Products
15.8.6.1.2.6. Others
15.8.6.1.3. APIs
15.8.6.1.4. Controlled
Drugs
15.8.6.1.5. Biopharmaceuticals
15.8.6.1.6. Clinical
Trials
15.8.6.1.7. Others
(First Aid etc.)
15.8.6.2. Nordic
Countries Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Temperature
15.8.6.2.1. 15-25°C
controlled
15.8.6.2.2. Refrigerated
2-8°C
15.8.6.2.3. Frozen
-24°C
15.8.6.2.4. Cryogenic
-170°C
15.8.6.2.5. Others
15.8.6.3. Nordic
Countries Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Services
15.8.6.3.1. End-to-End
Cold Chain Distribution
15.8.6.3.2. Time
and Temperature-Sensitive Shipments
15.8.6.3.3. Temperature-Controlled
GDP Vehicles
15.8.6.3.4. Packaging
15.8.6.3.5. Warehousing
15.8.6.3.6. Transportation
15.8.6.3.7. Container
Solutions
15.8.6.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.8.6.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.8.6.3.10. GDP
Compliant Distribution
15.8.6.3.11. Specialized
SOP’s
15.8.6.3.12. Others
15.8.6.4. Nordic
Countries Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Application
15.8.6.4.1. Regional
distributors
15.8.6.4.2. Multi-nationals
15.8.6.4.3. Others
15.8.6.5. Nordic
Countries Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Storage Techniques
15.8.6.5.1. Electrical
refrigeration
15.8.6.5.2. Dry
Ice
15.8.6.5.3. Gel
Packs
15.8.6.5.4. Liquid
nitrogen
15.8.6.5.5. Others
15.8.6.6. Nordic
Countries Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.6.6.1. Hospitals/Clinics
15.8.6.6.2. Research
Laboratories
15.8.6.6.3. Pharmacies
15.8.6.6.4. Ambulatory
Care Units
15.8.6.6.5. Others
15.8.6.7. Nordic
Countries Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Country
15.8.6.7.1. Denmark
15.8.6.7.2. Finland
15.8.6.7.3. Iceland
15.8.6.7.4. Sweden
15.8.6.7.5. Norway
15.8.7. Benelux
Union
15.8.7.1. Benelux
Union Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
15.8.7.1.1. Vaccines
15.8.7.1.2. Pharmaceuticals
15.8.7.1.2.1. High
Value Specialities
15.8.7.1.2.2. Biosimilars
15.8.7.1.2.3. Small
molecule innovative drugs
15.8.7.1.2.4. Generic
15.8.7.1.2.5. OTC
Products
15.8.7.1.2.6. Others
15.8.7.1.3. APIs
15.8.7.1.4. Controlled
Drugs
15.8.7.1.5. Biopharmaceuticals
15.8.7.1.6. Clinical
Trials
15.8.7.1.7. Others
(First Aid etc.)
15.8.7.2. Benelux
Union Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
15.8.7.2.1. 15-25°C
controlled
15.8.7.2.2. Refrigerated
2-8°C
15.8.7.2.3. Frozen
-24°C
15.8.7.2.4. Cryogenic
-170°C
15.8.7.2.5. Others
15.8.7.3. Benelux
Union Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
15.8.7.3.1. End-to-End
Cold Chain Distribution
15.8.7.3.2. Time
and Temperature-Sensitive Shipments
15.8.7.3.3. Temperature-Controlled
GDP Vehicles
15.8.7.3.4. Packaging
15.8.7.3.5. Warehousing
15.8.7.3.6. Transportation
15.8.7.3.7. Container
Solutions
15.8.7.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.8.7.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.8.7.3.10. GDP
Compliant Distribution
15.8.7.3.11. Specialized
SOP’s
15.8.7.3.12. Others
15.8.7.4. Benelux
Union Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.7.4.1. Regional
distributors
15.8.7.4.2. Multi-nationals
15.8.7.4.3. Others
15.8.7.5. Benelux
Union Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
15.8.7.5.1. Electrical
refrigeration
15.8.7.5.2. Dry
Ice
15.8.7.5.3. Gel
Packs
15.8.7.5.4. Liquid
nitrogen
15.8.7.5.5. Others
15.8.7.6. Benelux
Union Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
End Users
15.8.7.6.1. Hospitals/Clinics
15.8.7.6.2. Research
Laboratories
15.8.7.6.3. Pharmacies
15.8.7.6.4. Ambulatory
Care Units
15.8.7.6.5. Others
15.8.7.7. Benelux
Union Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Country
15.8.7.7.1. Belgium
15.8.7.7.2. The
Netherlands
15.8.7.7.3. Luxembourg
15.8.8. Rest of
Europe
15.8.8.1. Rest
of Europe Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Product
15.8.8.1.1. Vaccines
15.8.8.1.2. Pharmaceuticals
15.8.8.1.2.1. High
Value Specialities
15.8.8.1.2.2. Biosimilars
15.8.8.1.2.3. Small
molecule innovative drugs
15.8.8.1.2.4. Generic
15.8.8.1.2.5. OTC
Products
15.8.8.1.2.6. Others
15.8.8.1.3. APIs
15.8.8.1.4. Controlled
Drugs
15.8.8.1.5. Biopharmaceuticals
15.8.8.1.6. Clinical
Trials
15.8.8.1.7. Others
(First Aid etc.)
15.8.8.2. Rest
of Europe Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Temperature
15.8.8.2.1. 15-25°C
controlled
15.8.8.2.2. Refrigerated
2-8°C
15.8.8.2.3. Frozen
-24°C
15.8.8.2.4. Cryogenic
-170°C
15.8.8.2.5. Others
15.8.8.3. Rest
of Europe Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Services
15.8.8.3.1. End-to-End
Cold Chain Distribution
15.8.8.3.2. Time
and Temperature-Sensitive Shipments
15.8.8.3.3. Temperature-Controlled
GDP Vehicles
15.8.8.3.4. Packaging
15.8.8.3.5. Warehousing
15.8.8.3.6. Transportation
15.8.8.3.7. Container
Solutions
15.8.8.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
15.8.8.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
15.8.8.3.10. GDP
Compliant Distribution
15.8.8.3.11. Specialized
SOP’s
15.8.8.3.12. Others
15.8.8.4. Rest
of Europe Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Application
15.8.8.4.1. Regional
distributors
15.8.8.4.2. Multi-nationals
15.8.8.4.3. Others
15.8.8.5. Rest
of Europe Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Storage Techniques
15.8.8.5.1. Electrical
refrigeration
15.8.8.5.2. Dry
Ice
15.8.8.5.3. Gel
Packs
15.8.8.5.4. Liquid
nitrogen
15.8.8.5.5. Others
15.8.8.6. Rest
of Europe Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.8.6.1. Hospitals/Clinics
15.8.8.6.2. Research
Laboratories
15.8.8.6.3. Pharmacies
15.8.8.6.4. Ambulatory
Care Units
15.8.8.6.5. Others
15.9. Key
Segment for Channeling Investments
15.9.1. By
Country
15.9.2. By
Product
15.9.3. By
Temperature
15.9.4. By
Services
15.9.5. By
Application
15.9.6. By
Storage Techniques
15.9.7. By End
Users
16. Asia
Pacific Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 -
2028
16.1. Overview
16.1.1. Asia
Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn)
16.2. Asia
Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Product
16.2.1. Vaccines
16.2.2. Pharmaceuticals
16.2.2.1. High
Value Specialities
16.2.2.2. Biosimilars
16.2.2.3. Small
molecule innovative drugs
16.2.2.4. Generic
16.2.2.5. OTC
Products
16.2.2.6. Others
16.2.3. APIs
16.2.4. Controlled
Drugs
16.2.5. Biopharmaceuticals
16.2.6. Clinical
Trials
16.2.7. Others (First
Aid etc.)
16.3. Asia
Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Temperature
16.3.1. 15-25°C
controlled
16.3.2. Refrigerated
2-8°C
16.3.3. Frozen
-24°C
16.3.4. Cryogenic
-170°C
16.3.5. Others
16.4. Asia
Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Services
16.4.1. End-to-End
Cold Chain Distribution
16.4.2. Time
and Temperature-Sensitive Shipments
16.4.3. Temperature-Controlled
GDP Vehicles
16.4.4. Packaging
16.4.5. Warehousing
16.4.6. Transportation
16.4.7. Container
Solutions
16.4.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.4.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.4.10. GDP
Compliant Distribution
16.4.11. Specialized
SOP’s
16.4.12. Others
16.5. Asia
Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Application
16.5.1. Regional
distributors
16.5.2. Multi-nationals
16.5.3. Others
16.6. Asia
Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Storage Techniques
16.6.1. Electrical
refrigeration
16.6.2. Dry Ice
16.6.3. Gel
Packs
16.6.4. Liquid
nitrogen
16.6.5. Others
16.7. Asia
Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By End Users
16.7.1. Hospitals/Clinics
16.7.2. Research
Laboratories
16.7.3. Pharmacies
16.7.4. Ambulatory
Care Units
16.7.5. Others
16.8. Asia
Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Country
16.8.1. China
16.8.1.1. China
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
16.8.1.1.1. Vaccines
16.8.1.1.2. Pharmaceuticals
16.8.1.1.2.1. High
Value Specialities
16.8.1.1.2.2. Biosimilars
16.8.1.1.2.3. Small
molecule innovative drugs
16.8.1.1.2.4. Generic
16.8.1.1.2.5. OTC
Products
16.8.1.1.2.6. Others
16.8.1.1.3. APIs
16.8.1.1.4. Controlled
Drugs
16.8.1.1.5. Biopharmaceuticals
16.8.1.1.6. Clinical
Trials
16.8.1.1.7. Others
(First Aid etc.)
16.8.1.2. China
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
16.8.1.2.1. 15-25°C
controlled
16.8.1.2.2. Refrigerated
2-8°C
16.8.1.2.3. Frozen
-24°C
16.8.1.2.4. Cryogenic
-170°C
16.8.1.2.5. Others
16.8.1.3. China
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
16.8.1.3.1. End-to-End
Cold Chain Distribution
16.8.1.3.2. Time
and Temperature-Sensitive Shipments
16.8.1.3.3. Temperature-Controlled
GDP Vehicles
16.8.1.3.4. Packaging
16.8.1.3.5. Warehousing
16.8.1.3.6. Transportation
16.8.1.3.7. Container
Solutions
16.8.1.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.8.1.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.8.1.3.10. GDP
Compliant Distribution
16.8.1.3.11. Specialized
SOP’s
16.8.1.3.12. Others
16.8.1.4. China
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
16.8.1.4.1. Regional
distributors
16.8.1.4.2. Multi-nationals
16.8.1.4.3. Others
16.8.1.5. China
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
16.8.1.5.1. Electrical
refrigeration
16.8.1.5.2. Dry
Ice
16.8.1.5.3. Gel
Packs
16.8.1.5.4. Liquid
nitrogen
16.8.1.5.5. Others
16.8.1.6. China
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
16.8.1.6.1. Hospitals/Clinics
16.8.1.6.2. Research
Laboratories
16.8.1.6.3. Pharmacies
16.8.1.6.4. Ambulatory
Care Units
16.8.1.6.5. Others
16.8.2. Japan
16.8.2.1. Japan
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
16.8.2.1.1. Vaccines
16.8.2.1.2. Pharmaceuticals
16.8.2.1.2.1. High
Value Specialities
16.8.2.1.2.2. Biosimilars
16.8.2.1.2.3. Small
molecule innovative drugs
16.8.2.1.2.4. Generic
16.8.2.1.2.5. OTC
Products
16.8.2.1.2.6. Others
16.8.2.1.3. APIs
16.8.2.1.4. Controlled
Drugs
16.8.2.1.5. Biopharmaceuticals
16.8.2.1.6. Clinical
Trials
16.8.2.1.7. Others
(First Aid etc.)
16.8.2.2. Japan
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
16.8.2.2.1. 15-25°C
controlled
16.8.2.2.2. Refrigerated
2-8°C
16.8.2.2.3. Frozen
-24°C
16.8.2.2.4. Cryogenic
-170°C
16.8.2.2.5. Others
16.8.2.3. Japan
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
16.8.2.3.1. End-to-End
Cold Chain Distribution
16.8.2.3.2. Time
and Temperature-Sensitive Shipments
16.8.2.3.3. Temperature-Controlled
GDP Vehicles
16.8.2.3.4. Packaging
16.8.2.3.5. Warehousing
16.8.2.3.6. Transportation
16.8.2.3.7. Container
Solutions
16.8.2.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.8.2.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.8.2.3.10. GDP
Compliant Distribution
16.8.2.3.11. Specialized
SOP’s
16.8.2.3.12. Others
16.8.2.4. Japan
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By Application
16.8.2.4.1. Regional
distributors
16.8.2.4.2. Multi-nationals
16.8.2.4.3. Others
16.8.2.5. Japan
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
16.8.2.5.1. Electrical
refrigeration
16.8.2.5.2. Dry
Ice
16.8.2.5.3. Gel
Packs
16.8.2.5.4. Liquid
nitrogen
16.8.2.5.5. Others
16.8.2.6. Japan
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
16.8.2.6.1. Hospitals/Clinics
16.8.2.6.2. Research
Laboratories
16.8.2.6.3. Pharmacies
16.8.2.6.4. Ambulatory
Care Units
16.8.2.6.5. Others
16.8.3. India
16.8.3.1. India
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
16.8.3.1.1. Vaccines
16.8.3.1.2. Pharmaceuticals
16.8.3.1.2.1. High
Value Specialities
16.8.3.1.2.2. Biosimilars
16.8.3.1.2.3. Small
molecule innovative drugs
16.8.3.1.2.4. Generic
16.8.3.1.2.5. OTC
Products
16.8.3.1.2.6. Others
16.8.3.1.3. APIs
16.8.3.1.4. Controlled
Drugs
16.8.3.1.5. Biopharmaceuticals
16.8.3.1.6. Clinical
Trials
16.8.3.1.7. Others
(First Aid etc.)
16.8.3.2. India
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
16.8.3.2.1. 15-25°C
controlled
16.8.3.2.2. Refrigerated
2-8°C
16.8.3.2.3. Frozen
-24°C
16.8.3.2.4. Cryogenic
-170°C
16.8.3.2.5. Others
16.8.3.3. India
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
16.8.3.3.1. End-to-End
Cold Chain Distribution
16.8.3.3.2. Time
and Temperature-Sensitive Shipments
16.8.3.3.3. Temperature-Controlled
GDP Vehicles
16.8.3.3.4. Packaging
16.8.3.3.5. Warehousing
16.8.3.3.6. Transportation
16.8.3.3.7. Container
Solutions
16.8.3.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.8.3.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.8.3.3.10. GDP
Compliant Distribution
16.8.3.3.11. Specialized
SOP’s
16.8.3.3.12. Others
16.8.3.4. India
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
16.8.3.4.1. Regional
distributors
16.8.3.4.2. Multi-nationals
16.8.3.4.3. Others
16.8.3.5. India
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
16.8.3.5.1. Electrical
refrigeration
16.8.3.5.2. Dry
Ice
16.8.3.5.3. Gel
Packs
16.8.3.5.4. Liquid
nitrogen
16.8.3.5.5. Others
16.8.3.6. India
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
16.8.3.6.1. Hospitals/Clinics
16.8.3.6.2. Research
Laboratories
16.8.3.6.3. Pharmacies
16.8.3.6.4. Ambulatory
Care Units
16.8.3.6.5. Others
16.8.4. New
Zealand
16.8.4.1. New
Zealand Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Product
16.8.4.1.1. Vaccines
16.8.4.1.2. Pharmaceuticals
16.8.4.1.2.1. High
Value Specialities
16.8.4.1.2.2. Biosimilars
16.8.4.1.2.3. Small
molecule innovative drugs
16.8.4.1.2.4. Generic
16.8.4.1.2.5. OTC
Products
16.8.4.1.2.6. Others
16.8.4.1.3. APIs
16.8.4.1.4. Controlled
Drugs
16.8.4.1.5. Biopharmaceuticals
16.8.4.1.6. Clinical
Trials
16.8.4.1.7. Others
(First Aid etc.)
16.8.4.2. New
Zealand Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Temperature
16.8.4.2.1. 15-25°C
controlled
16.8.4.2.2. Refrigerated
2-8°C
16.8.4.2.3. Frozen
-24°C
16.8.4.2.4. Cryogenic
-170°C
16.8.4.2.5. Others
16.8.4.3. New
Zealand Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Services
16.8.4.3.1. End-to-End
Cold Chain Distribution
16.8.4.3.2. Time
and Temperature-Sensitive Shipments
16.8.4.3.3. Temperature-Controlled
GDP Vehicles
16.8.4.3.4. Packaging
16.8.4.3.5. Warehousing
16.8.4.3.6. Transportation
16.8.4.3.7. Container
Solutions
16.8.4.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.8.4.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.8.4.3.10. GDP
Compliant Distribution
16.8.4.3.11. Specialized
SOP’s
16.8.4.3.12. Others
16.8.4.4. New
Zealand Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Application
16.8.4.4.1. Regional
distributors
16.8.4.4.2. Multi-nationals
16.8.4.4.3. Others
16.8.4.5. New
Zealand Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Storage Techniques
16.8.4.5.1. Electrical
refrigeration
16.8.4.5.2. Dry
Ice
16.8.4.5.3. Gel
Packs
16.8.4.5.4. Liquid
nitrogen
16.8.4.5.5. Others
16.8.4.6. New
Zealand Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By End Users
16.8.4.6.1. Hospitals/Clinics
16.8.4.6.2. Research
Laboratories
16.8.4.6.3. Pharmacies
16.8.4.6.4. Ambulatory
Care Units
16.8.4.6.5. Others
16.8.5. Australia
16.8.5.1. Australia
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
16.8.5.1.1. Vaccines
16.8.5.1.2. Pharmaceuticals
16.8.5.1.2.1. High
Value Specialities
16.8.5.1.2.2. Biosimilars
16.8.5.1.2.3. Small
molecule innovative drugs
16.8.5.1.2.4. Generic
16.8.5.1.2.5. OTC
Products
16.8.5.1.2.6. Others
16.8.5.1.3. APIs
16.8.5.1.4. Controlled
Drugs
16.8.5.1.5. Biopharmaceuticals
16.8.5.1.6. Clinical
Trials
16.8.5.1.7. Others
(First Aid etc.)
16.8.5.2. Australia
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By Temperature
16.8.5.2.1. 15-25°C
controlled
16.8.5.2.2. Refrigerated
2-8°C
16.8.5.2.3. Frozen
-24°C
16.8.5.2.4. Cryogenic
-170°C
16.8.5.2.5. Others
16.8.5.3. Australia
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
16.8.5.3.1. End-to-End
Cold Chain Distribution
16.8.5.3.2. Time
and Temperature-Sensitive Shipments
16.8.5.3.3. Temperature-Controlled
GDP Vehicles
16.8.5.3.4. Packaging
16.8.5.3.5. Warehousing
16.8.5.3.6. Transportation
16.8.5.3.7. Container
Solutions
16.8.5.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.8.5.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.8.5.3.10. GDP
Compliant Distribution
16.8.5.3.11. Specialized
SOP’s
16.8.5.3.12. Others
16.8.5.4. Australia
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
16.8.5.4.1. Regional
distributors
16.8.5.4.2. Multi-nationals
16.8.5.4.3. Others
16.8.5.5. Australia
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
16.8.5.5.1. Electrical
refrigeration
16.8.5.5.2. Dry
Ice
16.8.5.5.3. Gel
Packs
16.8.5.5.4. Liquid
nitrogen
16.8.5.5.5. Others
16.8.5.6. Australia
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
16.8.5.6.1. Hospitals/Clinics
16.8.5.6.2. Research
Laboratories
16.8.5.6.3. Pharmacies
16.8.5.6.4. Ambulatory
Care Units
16.8.5.6.5. Others
16.8.6. South
Korea
16.8.6.1. South
Korea Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
16.8.6.1.1. Vaccines
16.8.6.1.2. Pharmaceuticals
16.8.6.1.2.1. High
Value Specialities
16.8.6.1.2.2. Biosimilars
16.8.6.1.2.3. Small
molecule innovative drugs
16.8.6.1.2.4. Generic
16.8.6.1.2.5. OTC
Products
16.8.6.1.2.6. Others
16.8.6.1.3. APIs
16.8.6.1.4. Controlled
Drugs
16.8.6.1.5. Biopharmaceuticals
16.8.6.1.6. Clinical
Trials
16.8.6.1.7. Others
(First Aid etc.)
16.8.6.2. South
Korea Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
16.8.6.2.1. 15-25°C
controlled
16.8.6.2.2. Refrigerated
2-8°C
16.8.6.2.3. Frozen
-24°C
16.8.6.2.4. Cryogenic
-170°C
16.8.6.2.5. Others
16.8.6.3. South
Korea Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
16.8.6.3.1. End-to-End
Cold Chain Distribution
16.8.6.3.2. Time
and Temperature-Sensitive Shipments
16.8.6.3.3. Temperature-Controlled
GDP Vehicles
16.8.6.3.4. Packaging
16.8.6.3.5. Warehousing
16.8.6.3.6. Transportation
16.8.6.3.7. Container
Solutions
16.8.6.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.8.6.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.8.6.3.10. GDP
Compliant Distribution
16.8.6.3.11. Specialized
SOP’s
16.8.6.3.12. Others
16.8.6.4. South
Korea Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
16.8.6.4.1. Regional
distributors
16.8.6.4.2. Multi-nationals
16.8.6.4.3. Others
16.8.6.5. South
Korea Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
16.8.6.5.1. Electrical
refrigeration
16.8.6.5.2. Dry
Ice
16.8.6.5.3. Gel
Packs
16.8.6.5.4. Liquid
nitrogen
16.8.6.5.5. Others
16.8.6.6. South
Korea Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
End Users
16.8.6.6.1. Hospitals/Clinics
16.8.6.6.2. Research
Laboratories
16.8.6.6.3. Pharmacies
16.8.6.6.4. Ambulatory
Care Units
16.8.6.6.5. Others
16.8.7. Southeast
Asia
16.8.7.1. Southeast
Asia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
16.8.7.1.1. Vaccines
16.8.7.1.2. Pharmaceuticals
16.8.7.1.2.1. High
Value Specialities
16.8.7.1.2.2. Biosimilars
16.8.7.1.2.3. Small
molecule innovative drugs
16.8.7.1.2.4. Generic
16.8.7.1.2.5. OTC
Products
16.8.7.1.2.6. Others
16.8.7.1.3. APIs
16.8.7.1.4. Controlled
Drugs
16.8.7.1.5. Biopharmaceuticals
16.8.7.1.6. Clinical
Trials
16.8.7.1.7. Others
(First Aid etc.)
16.8.7.2. Southeast
Asia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
16.8.7.2.1. 15-25°C
controlled
16.8.7.2.2. Refrigerated
2-8°C
16.8.7.2.3. Frozen
-24°C
16.8.7.2.4. Cryogenic
-170°C
16.8.7.2.5. Others
16.8.7.3. Southeast
Asia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
16.8.7.3.1. End-to-End
Cold Chain Distribution
16.8.7.3.2. Time
and Temperature-Sensitive Shipments
16.8.7.3.3. Temperature-Controlled
GDP Vehicles
16.8.7.3.4. Packaging
16.8.7.3.5. Warehousing
16.8.7.3.6. Transportation
16.8.7.3.7. Container
Solutions
16.8.7.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.8.7.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.8.7.3.10. GDP
Compliant Distribution
16.8.7.3.11. Specialized
SOP’s
16.8.7.3.12. Others
16.8.7.4. Southeast
Asia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
16.8.7.4.1. Regional
distributors
16.8.7.4.2. Multi-nationals
16.8.7.4.3. Others
16.8.7.5. Southeast
Asia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
16.8.7.5.1. Electrical
refrigeration
16.8.7.5.2. Dry
Ice
16.8.7.5.3. Gel
Packs
16.8.7.5.4. Liquid
nitrogen
16.8.7.5.5. Others
16.8.7.6. Southeast
Asia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
End Users
16.8.7.6.1. Hospitals/Clinics
16.8.7.6.2. Research
Laboratories
16.8.7.6.3. Pharmacies
16.8.7.6.4. Ambulatory
Care Units
16.8.7.6.5. Others
16.8.7.7. Southeast
Asia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Country
16.8.7.7.1. Indonesia
16.8.7.7.2. Thailand
16.8.7.7.3. Malaysia
16.8.7.7.4. Singapore
16.8.7.7.5. Rest
of Southeast Asia
16.8.8. Rest of
Asia Pacific
16.8.8.1. Rest
of Asia Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Product
16.8.8.1.1. Vaccines
16.8.8.1.2. Pharmaceuticals
16.8.8.1.2.1. High
Value Specialities
16.8.8.1.2.2. Biosimilars
16.8.8.1.2.3. Small
molecule innovative drugs
16.8.8.1.2.4. Generic
16.8.8.1.2.5. OTC
Products
16.8.8.1.2.6. Others
16.8.8.1.3. APIs
16.8.8.1.4. Controlled
Drugs
16.8.8.1.5. Biopharmaceuticals
16.8.8.1.6. Clinical
Trials
16.8.8.1.7. Others
(First Aid etc.)
16.8.8.2. Rest
of Asia Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Temperature
16.8.8.2.1. 15-25°C
controlled
16.8.8.2.2. Refrigerated
2-8°C
16.8.8.2.3. Frozen
-24°C
16.8.8.2.4. Cryogenic
-170°C
16.8.8.2.5. Others
16.8.8.3. Rest
of Asia Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Services
16.8.8.3.1. End-to-End
Cold Chain Distribution
16.8.8.3.2. Time
and Temperature-Sensitive Shipments
16.8.8.3.3. Temperature-Controlled
GDP Vehicles
16.8.8.3.4. Packaging
16.8.8.3.5. Warehousing
16.8.8.3.6. Transportation
16.8.8.3.7. Container
Solutions
16.8.8.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
16.8.8.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
16.8.8.3.10. GDP
Compliant Distribution
16.8.8.3.11. Specialized
SOP’s
16.8.8.3.12. Others
16.8.8.4. Rest
of Asia Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Application
16.8.8.4.1. Regional
distributors
16.8.8.4.2. Multi-nationals
16.8.8.4.3. Others
16.8.8.5. Rest
of Asia Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Storage Techniques
16.8.8.5.1. Electrical
refrigeration
16.8.8.5.2. Dry
Ice
16.8.8.5.3. Gel
Packs
16.8.8.5.4. Liquid
nitrogen
16.8.8.5.5. Others
16.8.8.6. Rest
of Asia Pacific Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By End Users
16.8.8.6.1. Hospitals/Clinics
16.8.8.6.2. Research
Laboratories
16.8.8.6.3. Pharmacies
16.8.8.6.4. Ambulatory
Care Units
16.8.8.6.5. Others
16.9. Key
Segment for Channeling Investments
16.9.1. By
Country
16.9.2. By
Product
16.9.3. By
Temperature
16.9.4. By
Services
16.9.5. By
Application
16.9.6. By
Storage Techniques
16.9.7. By End
Users
17. Middle
East and Africa Healthcare Cold Chain Logistics Market Analysis and Forecasts,
2020 - 2028
17.1. Overview
17.1.1. Middle
East and Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn)
17.2. Middle
East and Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Product
17.2.1. Vaccines
17.2.2. Pharmaceuticals
17.2.2.1. High
Value Specialities
17.2.2.2. Biosimilars
17.2.2.3. Small
molecule innovative drugs
17.2.2.4. Generic
17.2.2.5. OTC
Products
17.2.2.6. Others
17.2.3. APIs
17.2.4. Controlled
Drugs
17.2.5. Biopharmaceuticals
17.2.6. Clinical
Trials
17.2.7. Others
(First Aid etc.)
17.3. Middle
East and Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Temperature
17.3.1. 15-25°C
controlled
17.3.2. Refrigerated
2-8°C
17.3.3. Frozen
-24°C
17.3.4. Cryogenic
-170°C
17.3.5. Others
17.4. Middle
East and Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Services
17.4.1. End-to-End
Cold Chain Distribution
17.4.2. Time
and Temperature-Sensitive Shipments
17.4.3. Temperature-Controlled
GDP Vehicles
17.4.4. Packaging
17.4.5. Warehousing
17.4.6. Transportation
17.4.7. Container
Solutions
17.4.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
17.4.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
17.4.10. GDP
Compliant Distribution
17.4.11. Specialized
SOP’s
17.4.12. Others
17.5. Middle
East and Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Application
17.5.1. Regional
distributors
17.5.2. Multi-nationals
17.5.3. Others
17.6. Middle
East and Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Storage Techniques
17.6.1. Electrical
refrigeration
17.6.2. Dry Ice
17.6.3. Gel
Packs
17.6.4. Liquid
nitrogen
17.6.5. Others
17.7. Middle
East and Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By End Users
17.7.1. Hospitals/Clinics
17.7.2. Research
Laboratories
17.7.3. Pharmacies
17.7.4. Ambulatory
Care Units
17.7.5. Others
17.8. Middle
East and Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Country
17.8.1. Saudi
Arabia
17.8.1.1. Saudi
Arabia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Product
17.8.1.1.1. Vaccines
17.8.1.1.2. Pharmaceuticals
17.8.1.1.2.1. High
Value Specialities
17.8.1.1.2.2. Biosimilars
17.8.1.1.2.3. Small
molecule innovative drugs
17.8.1.1.2.4. Generic
17.8.1.1.2.5. OTC
Products
17.8.1.1.2.6. Others
17.8.1.1.3. APIs
17.8.1.1.4. Controlled
Drugs
17.8.1.1.5. Biopharmaceuticals
17.8.1.1.6. Clinical
Trials
17.8.1.1.7. Others
(First Aid etc.)
17.8.1.2. Saudi
Arabia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Temperature
17.8.1.2.1. 15-25°C
controlled
17.8.1.2.2. Refrigerated
2-8°C
17.8.1.2.3. Frozen
-24°C
17.8.1.2.4. Cryogenic
-170°C
17.8.1.2.5. Others
17.8.1.3. Saudi
Arabia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Services
17.8.1.3.1. End-to-End
Cold Chain Distribution
17.8.1.3.2. Time
and Temperature-Sensitive Shipments
17.8.1.3.3. Temperature-Controlled
GDP Vehicles
17.8.1.3.4. Packaging
17.8.1.3.5. Warehousing
17.8.1.3.6. Transportation
17.8.1.3.7. Container
Solutions
17.8.1.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
17.8.1.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
17.8.1.3.10. GDP
Compliant Distribution
17.8.1.3.11. Specialized
SOP’s
17.8.1.3.12. Others
17.8.1.4. Saudi
Arabia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Application
17.8.1.4.1. Regional
distributors
17.8.1.4.2. Multi-nationals
17.8.1.4.3. Others
17.8.1.5. Saudi
Arabia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Storage Techniques
17.8.1.5.1. Electrical
refrigeration
17.8.1.5.2. Dry
Ice
17.8.1.5.3. Gel
Packs
17.8.1.5.4. Liquid
nitrogen
17.8.1.5.5. Others
17.8.1.6. Saudi
Arabia Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By End Users
17.8.1.6.1. Hospitals/Clinics
17.8.1.6.2. Research
Laboratories
17.8.1.6.3. Pharmacies
17.8.1.6.4. Ambulatory
Care Units
17.8.1.6.5. Others
17.8.2. UAE
17.8.2.1. UAE
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
17.8.2.1.1. Vaccines
17.8.2.1.2. Pharmaceuticals
17.8.2.1.2.1. High
Value Specialities
17.8.2.1.2.2. Biosimilars
17.8.2.1.2.3. Small
molecule innovative drugs
17.8.2.1.2.4. Generic
17.8.2.1.2.5. OTC
Products
17.8.2.1.2.6. Others
17.8.2.1.3. APIs
17.8.2.1.4. Controlled
Drugs
17.8.2.1.5. Biopharmaceuticals
17.8.2.1.6. Clinical
Trials
17.8.2.1.7. Others
(First Aid etc.)
17.8.2.2. UAE
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By Temperature
17.8.2.2.1. 15-25°C
controlled
17.8.2.2.2. Refrigerated
2-8°C
17.8.2.2.3. Frozen
-24°C
17.8.2.2.4. Cryogenic
-170°C
17.8.2.2.5. Others
17.8.2.3. UAE
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
17.8.2.3.1. End-to-End
Cold Chain Distribution
17.8.2.3.2. Time
and Temperature-Sensitive Shipments
17.8.2.3.3. Temperature-Controlled
GDP Vehicles
17.8.2.3.4. Packaging
17.8.2.3.5. Warehousing
17.8.2.3.6. Transportation
17.8.2.3.7. Container
Solutions
17.8.2.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
17.8.2.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
17.8.2.3.10. GDP
Compliant Distribution
17.8.2.3.11. Specialized
SOP’s
17.8.2.3.12. Others
17.8.2.4. UAE
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
17.8.2.4.1. Regional
distributors
17.8.2.4.2. Multi-nationals
17.8.2.4.3. Others
17.8.2.5. UAE
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
17.8.2.5.1. Electrical
refrigeration
17.8.2.5.2. Dry
Ice
17.8.2.5.3. Gel
Packs
17.8.2.5.4. Liquid
nitrogen
17.8.2.5.5. Others
17.8.2.6. UAE
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
17.8.2.6.1. Hospitals/Clinics
17.8.2.6.2. Research
Laboratories
17.8.2.6.3. Pharmacies
17.8.2.6.4. Ambulatory
Care Units
17.8.2.6.5. Others
17.8.3. Egypt
17.8.3.1. Egypt
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
17.8.3.1.1. Vaccines
17.8.3.1.2. Pharmaceuticals
17.8.3.1.2.1. High
Value Specialities
17.8.3.1.2.2. Biosimilars
17.8.3.1.2.3. Small
molecule innovative drugs
17.8.3.1.2.4. Generic
17.8.3.1.2.5. OTC
Products
17.8.3.1.2.6. Others
17.8.3.1.3. APIs
17.8.3.1.4. Controlled
Drugs
17.8.3.1.5. Biopharmaceuticals
17.8.3.1.6. Clinical
Trials
17.8.3.1.7. Others
(First Aid etc.)
17.8.3.2. Egypt
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
17.8.3.2.1. 15-25°C
controlled
17.8.3.2.2. Refrigerated
2-8°C
17.8.3.2.3. Frozen
-24°C
17.8.3.2.4. Cryogenic
-170°C
17.8.3.2.5. Others
17.8.3.3. Egypt
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
17.8.3.3.1. End-to-End
Cold Chain Distribution
17.8.3.3.2. Time
and Temperature-Sensitive Shipments
17.8.3.3.3. Temperature-Controlled
GDP Vehicles
17.8.3.3.4. Packaging
17.8.3.3.5. Warehousing
17.8.3.3.6. Transportation
17.8.3.3.7. Container
Solutions
17.8.3.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
17.8.3.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
17.8.3.3.10. GDP
Compliant Distribution
17.8.3.3.11. Specialized
SOP’s
17.8.3.3.12. Others
17.8.3.4. Egypt
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
17.8.3.4.1. Regional
distributors
17.8.3.4.2. Multi-nationals
17.8.3.4.3. Others
17.8.3.5. Egypt
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
17.8.3.5.1. Electrical
refrigeration
17.8.3.5.2. Dry
Ice
17.8.3.5.3. Gel
Packs
17.8.3.5.4. Liquid
nitrogen
17.8.3.5.5. Others
17.8.3.6. Egypt
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
17.8.3.6.1. Hospitals/Clinics
17.8.3.6.2. Research
Laboratories
17.8.3.6.3. Pharmacies
17.8.3.6.4. Ambulatory
Care Units
17.8.3.6.5. Others
17.8.4. Kuwait
17.8.4.1. Kuwait
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
17.8.4.1.1. Vaccines
17.8.4.1.2. Pharmaceuticals
17.8.4.1.2.1. High
Value Specialities
17.8.4.1.2.2. Biosimilars
17.8.4.1.2.3. Small
molecule innovative drugs
17.8.4.1.2.4. Generic
17.8.4.1.2.5. OTC
Products
17.8.4.1.2.6. Others
17.8.4.1.3. APIs
17.8.4.1.4. Controlled
Drugs
17.8.4.1.5. Biopharmaceuticals
17.8.4.1.6. Clinical
Trials
17.8.4.1.7. Others
(First Aid etc.)
17.8.4.2. Kuwait
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
17.8.4.2.1. 15-25°C
controlled
17.8.4.2.2. Refrigerated
2-8°C
17.8.4.2.3. Frozen
-24°C
17.8.4.2.4. Cryogenic
-170°C
17.8.4.2.5. Others
17.8.4.3. Kuwait
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
17.8.4.3.1. End-to-End
Cold Chain Distribution
17.8.4.3.2. Time
and Temperature-Sensitive Shipments
17.8.4.3.3. Temperature-Controlled
GDP Vehicles
17.8.4.3.4. Packaging
17.8.4.3.5. Warehousing
17.8.4.3.6. Transportation
17.8.4.3.7. Container
Solutions
17.8.4.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
17.8.4.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
17.8.4.3.10. GDP
Compliant Distribution
17.8.4.3.11. Specialized
SOP’s
17.8.4.3.12. Others
17.8.4.4. Kuwait
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
17.8.4.4.1. Regional
distributors
17.8.4.4.2. Multi-nationals
17.8.4.4.3. Others
17.8.4.5. Kuwait
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
17.8.4.5.1. Electrical
refrigeration
17.8.4.5.2. Dry
Ice
17.8.4.5.3. Gel
Packs
17.8.4.5.4. Liquid
nitrogen
17.8.4.5.5. Others
17.8.4.6. Kuwait
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
17.8.4.6.1. Hospitals/Clinics
17.8.4.6.2. Research
Laboratories
17.8.4.6.3. Pharmacies
17.8.4.6.4. Ambulatory
Care Units
17.8.4.6.5. Others
17.8.5. South
Africa
17.8.5.1. South
Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Product
17.8.5.1.1. Vaccines
17.8.5.1.2. Pharmaceuticals
17.8.5.1.2.1. High
Value Specialities
17.8.5.1.2.2. Biosimilars
17.8.5.1.2.3. Small
molecule innovative drugs
17.8.5.1.2.4. Generic
17.8.5.1.2.5. OTC
Products
17.8.5.1.2.6. Others
17.8.5.1.3. APIs
17.8.5.1.4. Controlled
Drugs
17.8.5.1.5. Biopharmaceuticals
17.8.5.1.6. Clinical
Trials
17.8.5.1.7. Others
(First Aid etc.)
17.8.5.2. South
Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Temperature
17.8.5.2.1. 15-25°C
controlled
17.8.5.2.2. Refrigerated
2-8°C
17.8.5.2.3. Frozen
-24°C
17.8.5.2.4. Cryogenic
-170°C
17.8.5.2.5. Others
17.8.5.3. South
Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Services
17.8.5.3.1. End-to-End
Cold Chain Distribution
17.8.5.3.2. Time
and Temperature-Sensitive Shipments
17.8.5.3.3. Temperature-Controlled
GDP Vehicles
17.8.5.3.4. Packaging
17.8.5.3.5. Warehousing
17.8.5.3.6. Transportation
17.8.5.3.7. Container
Solutions
17.8.5.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
17.8.5.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
17.8.5.3.10. GDP
Compliant Distribution
17.8.5.3.11. Specialized
SOP’s
17.8.5.3.12. Others
17.8.5.4. South
Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Application
17.8.5.4.1. Regional
distributors
17.8.5.4.2. Multi-nationals
17.8.5.4.3. Others
17.8.5.5. South
Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Storage Techniques
17.8.5.5.1. Electrical
refrigeration
17.8.5.5.2. Dry
Ice
17.8.5.5.3. Gel
Packs
17.8.5.5.4. Liquid
nitrogen
17.8.5.5.5. Others
17.8.5.6. South
Africa Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By End Users
17.8.5.6.1. Hospitals/Clinics
17.8.5.6.2. Research
Laboratories
17.8.5.6.3. Pharmacies
17.8.5.6.4. Ambulatory
Care Units
17.8.5.6.5. Others
17.8.6. Rest of
Middle East & Africa
17.8.6.1. Rest
of Middle East & Africa Healthcare Cold Chain Logistics Market Revenue (US$
Mn) and Forecasts, By Product
17.8.6.1.1. Vaccines
17.8.6.1.2. Pharmaceuticals
17.8.6.1.2.1. High
Value Specialities
17.8.6.1.2.2. Biosimilars
17.8.6.1.2.3. Small
molecule innovative drugs
17.8.6.1.2.4. Generic
17.8.6.1.2.5. OTC
Products
17.8.6.1.2.6. Others
17.8.6.1.3. APIs
17.8.6.1.4. Controlled
Drugs
17.8.6.1.5. Biopharmaceuticals
17.8.6.1.6. Clinical
Trials
17.8.6.1.7. Others
(First Aid etc.)
17.8.6.2. Rest
of Middle East & Africa Healthcare Cold Chain Logistics Market Revenue (US$
Mn) and Forecasts, By Temperature
17.8.6.2.1. 15-25°C
controlled
17.8.6.2.2. Refrigerated
2-8°C
17.8.6.2.3. Frozen
-24°C
17.8.6.2.4. Cryogenic
-170°C
17.8.6.2.5. Others
17.8.6.3. Rest
of Middle East & Africa Healthcare Cold Chain Logistics Market Revenue (US$
Mn) and Forecasts, By Services
17.8.6.3.1. End-to-End
Cold Chain Distribution
17.8.6.3.2. Time
and Temperature-Sensitive Shipments
17.8.6.3.3. Temperature-Controlled
GDP Vehicles
17.8.6.3.4. Packaging
17.8.6.3.5. Warehousing
17.8.6.3.6. Transportation
17.8.6.3.7. Container
Solutions
17.8.6.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
17.8.6.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
17.8.6.3.10. GDP
Compliant Distribution
17.8.6.3.11. Specialized
SOP’s
17.8.6.3.12. Others
17.8.6.4. Rest
of Middle East & Africa Healthcare Cold Chain Logistics Market Revenue (US$
Mn) and Forecasts, By Application
17.8.6.4.1. Regional
distributors
17.8.6.4.2. Multi-nationals
17.8.6.4.3. Others
17.8.6.5. Rest
of Middle East & Africa Healthcare Cold Chain Logistics Market Revenue (US$
Mn) and Forecasts, By Storage Techniques
17.8.6.5.1. Electrical
refrigeration
17.8.6.5.2. Dry
Ice
17.8.6.5.3. Gel
Packs
17.8.6.5.4. Liquid
nitrogen
17.8.6.5.5. Others
17.8.6.6. Rest
of Middle East & Africa Healthcare Cold Chain Logistics Market Revenue (US$
Mn) and Forecasts, By End Users
17.8.6.6.1. Hospitals/Clinics
17.8.6.6.2. Research
Laboratories
17.8.6.6.3. Pharmacies
17.8.6.6.4. Ambulatory
Care Units
17.8.6.6.5. Others
17.9. Key
Segment for Channeling Investments
17.9.1. By
Country
17.9.2. By
Product
17.9.3. By
Temperature
17.9.4. By
Services
17.9.5. By
Application
17.9.6. By
Storage Techniques
17.9.7. By End
Users
18. Latin
America Healthcare Cold Chain Logistics Market Analysis and Forecasts, 2020 -
2028
18.1. Overview
18.1.1. Latin
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn)
18.2. Latin
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Product
18.2.1. Vaccines
18.2.2. Pharmaceuticals
18.2.2.1. High
Value Specialities
18.2.2.2. Biosimilars
18.2.2.3. Small
molecule innovative drugs
18.2.2.4. Generic
18.2.2.5. OTC
Products
18.2.2.6. Others
18.2.3. APIs
18.2.4. Controlled
Drugs
18.2.5. Biopharmaceuticals
18.2.6. Clinical
Trials
18.2.7. Others
(First Aid etc.)
18.3. Latin
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Temperature
18.3.1. 15-25°C
controlled
18.3.2. Refrigerated
2-8°C
18.3.3. Frozen
-24°C
18.3.4. Cryogenic
-170°C
18.3.5. Others
18.4. Latin
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Services
18.4.1. End-to-End
Cold Chain Distribution
18.4.2. Time
and Temperature-Sensitive Shipments
18.4.3. Temperature-Controlled
GDP Vehicles
18.4.4. Packaging
18.4.5. Warehousing
18.4.6. Transportation
18.4.7. Container
Solutions
18.4.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
18.4.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
18.4.10. GDP
Compliant Distribution
18.4.11. Specialized
SOP’s
18.4.12. Others
18.5. Latin
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Application
18.5.1. Regional
distributors
18.5.2. Multi-nationals
18.5.3. Others
18.6. Latin
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
18.6.1. Electrical
refrigeration
18.6.2. Dry Ice
18.6.3. Gel
Packs
18.6.4. Liquid
nitrogen
18.6.5. Others
18.7. Latin
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By End Users
18.7.1. Hospitals/Clinics
18.7.2. Research
Laboratories
18.7.3. Pharmacies
18.7.4. Ambulatory
Care Units
18.7.5. Others
18.8. Latin
America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts,
By Country
18.8.1. Brazil
18.8.1.1. Brazil
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
18.8.1.1.1. Vaccines
18.8.1.1.2. Pharmaceuticals
18.8.1.1.2.1. High
Value Specialities
18.8.1.1.2.2. Biosimilars
18.8.1.1.2.3. Small
molecule innovative drugs
18.8.1.1.2.4. Generic
18.8.1.1.2.5. OTC
Products
18.8.1.1.2.6. Others
18.8.1.1.3. APIs
18.8.1.1.4. Controlled
Drugs
18.8.1.1.5. Biopharmaceuticals
18.8.1.1.6. Clinical
Trials
18.8.1.1.7. Others
(First Aid etc.)
18.8.1.2. Brazil
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
18.8.1.2.1. 15-25°C
controlled
18.8.1.2.2. Refrigerated
2-8°C
18.8.1.2.3. Frozen
-24°C
18.8.1.2.4. Cryogenic
-170°C
18.8.1.2.5. Others
18.8.1.3. Brazil
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
18.8.1.3.1. End-to-End
Cold Chain Distribution
18.8.1.3.2. Time
and Temperature-Sensitive Shipments
18.8.1.3.3. Temperature-Controlled
GDP Vehicles
18.8.1.3.4. Packaging
18.8.1.3.5. Warehousing
18.8.1.3.6. Transportation
18.8.1.3.7. Container
Solutions
18.8.1.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
18.8.1.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
18.8.1.3.10. GDP
Compliant Distribution
18.8.1.3.11. Specialized
SOP’s
18.8.1.3.12. Others
18.8.1.4. Brazil
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
18.8.1.4.1. Regional
distributors
18.8.1.4.2. Multi-nationals
18.8.1.4.3. Others
18.8.1.5. Brazil
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
18.8.1.5.1. Electrical
refrigeration
18.8.1.5.2. Dry
Ice
18.8.1.5.3. Gel
Packs
18.8.1.5.4. Liquid
nitrogen
18.8.1.5.5. Others
18.8.1.6. Brazil
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
18.8.1.6.1. Hospitals/Clinics
18.8.1.6.2. Research
Laboratories
18.8.1.6.3. Pharmacies
18.8.1.6.4. Ambulatory
Care Units
18.8.1.6.5. Others
18.8.2. Argentina
18.8.2.1. Argentina
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Product
18.8.2.1.1. Vaccines
18.8.2.1.2. Pharmaceuticals
18.8.2.1.2.1. High
Value Specialities
18.8.2.1.2.2. Biosimilars
18.8.2.1.2.3. Small
molecule innovative drugs
18.8.2.1.2.4. Generic
18.8.2.1.2.5. OTC
Products
18.8.2.1.2.6. Others
18.8.2.1.3. APIs
18.8.2.1.4. Controlled
Drugs
18.8.2.1.5. Biopharmaceuticals
18.8.2.1.6. Clinical
Trials
18.8.2.1.7. Others
(First Aid etc.)
18.8.2.2. Argentina
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Temperature
18.8.2.2.1. 15-25°C
controlled
18.8.2.2.2. Refrigerated
2-8°C
18.8.2.2.3. Frozen
-24°C
18.8.2.2.4. Cryogenic
-170°C
18.8.2.2.5. Others
18.8.2.3. Argentina
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Services
18.8.2.3.1. End-to-End
Cold Chain Distribution
18.8.2.3.2. Time
and Temperature-Sensitive Shipments
18.8.2.3.3. Temperature-Controlled
GDP Vehicles
18.8.2.3.4. Packaging
18.8.2.3.5. Warehousing
18.8.2.3.6. Transportation
18.8.2.3.7. Container
Solutions
18.8.2.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
18.8.2.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
18.8.2.3.10. GDP
Compliant Distribution
18.8.2.3.11. Specialized
SOP’s
18.8.2.3.12. Others
18.8.2.4. Argentina
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Application
18.8.2.4.1. Regional
distributors
18.8.2.4.2. Multi-nationals
18.8.2.4.3. Others
18.8.2.5. Argentina
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By
Storage Techniques
18.8.2.5.1. Electrical
refrigeration
18.8.2.5.2. Dry
Ice
18.8.2.5.3. Gel
Packs
18.8.2.5.4. Liquid
nitrogen
18.8.2.5.5. Others
18.8.2.6. Argentina
Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and Forecasts, By End
Users
18.8.2.6.1. Hospitals/Clinics
18.8.2.6.2. Research
Laboratories
18.8.2.6.3. Pharmacies
18.8.2.6.4. Ambulatory
Care Units
18.8.2.6.5. Others
18.8.3. Rest of
Latin America
18.8.3.1. Rest
of Latin America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Product
18.8.3.1.1. Vaccines
18.8.3.1.2. Pharmaceuticals
18.8.3.1.2.1. High
Value Specialities
18.8.3.1.2.2. Biosimilars
18.8.3.1.2.3. Small
molecule innovative drugs
18.8.3.1.2.4. Generic
18.8.3.1.2.5. OTC
Products
18.8.3.1.2.6. Others
18.8.3.1.3. APIs
18.8.3.1.4. Controlled
Drugs
18.8.3.1.5. Biopharmaceuticals
18.8.3.1.6. Clinical
Trials
18.8.3.1.7. Others
(First Aid etc.)
18.8.3.2. Rest
of Latin America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Temperature
18.8.3.2.1. 15-25°C
controlled
18.8.3.2.2. Refrigerated
2-8°C
18.8.3.2.3. Frozen
-24°C
18.8.3.2.4. Cryogenic
-170°C
18.8.3.2.5. Others
18.8.3.3. Rest
of Latin America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Services
18.8.3.3.1. End-to-End
Cold Chain Distribution
18.8.3.3.2. Time
and Temperature-Sensitive Shipments
18.8.3.3.3. Temperature-Controlled
GDP Vehicles
18.8.3.3.4. Packaging
18.8.3.3.5. Warehousing
18.8.3.3.6. Transportation
18.8.3.3.7. Container
Solutions
18.8.3.3.8. Thermal
Pallet Covers and Multi-Use Insulation Blankets
18.8.3.3.9. Reverse
Logistics for Product Recalls, Returned, and Salvaged Products
18.8.3.3.10. GDP
Compliant Distribution
18.8.3.3.11. Specialized
SOP’s
18.8.3.3.12. Others
18.8.3.4. Rest
of Latin America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Application
18.8.3.4.1. Regional
distributors
18.8.3.4.2. Multi-nationals
18.8.3.4.3. Others
18.8.3.5. Rest
of Latin America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By Storage Techniques
18.8.3.5.1. Electrical
refrigeration
18.8.3.5.2. Dry
Ice
18.8.3.5.3. Gel
Packs
18.8.3.5.4. Liquid
nitrogen
18.8.3.5.5. Others
18.8.3.6. Rest
of Latin America Healthcare Cold Chain Logistics Market Revenue (US$ Mn) and
Forecasts, By End Users
18.8.3.6.1. Hospitals/Clinics
18.8.3.6.2. Research
Laboratories
18.8.3.6.3. Pharmacies
18.8.3.6.4. Ambulatory
Care Units
18.8.3.6.5. Others
18.9. Key
Segment for Channeling Investments
18.9.1. By
Country
18.9.2. By
Product
18.9.3. By
Temperature
18.9.4. By
Services
18.9.5. By
Application
18.9.6. By
Storage Techniques
18.9.7. By End
Users
19. Competitive
Benchmarking
19.1. Market
Share Analysis, 2019
19.2. Global
Presence and Growth Strategies
19.2.1. Mergers
and Acquisitions
19.2.2. Product
Launches
19.2.3. Investments
Trends
19.2.4. R&D
Initiatives
20. Player
Profiles
20.1. American
Airlines, Inc.
20.1.1. Company
Details
20.1.2. Company
Overview
20.1.3. Product
Offerings
20.1.4. Key
Developments
20.1.5. Financial
Analysis
20.1.6. SWOT
Analysis
20.1.7. Business
Strategies
20.2. AmerisourceBergen
Corporation
20.2.1. Company
Details
20.2.2. Company
Overview
20.2.3. Product
Offerings
20.2.4. Key
Developments
20.2.5. Financial
Analysis
20.2.6. SWOT
Analysis
20.2.7. Business Strategies
20.3. Cardinal Health.
20.3.1. Company
Details
20.3.2. Company
Overview
20.3.3. Product
Offerings
20.3.4. Key
Developments
20.3.5. Financial
Analysis
20.3.6. SWOT
Analysis
20.3.7. Business Strategies
20.4. CAVALIER LOGISITICS
20.4.1. Company
Details
20.4.2. Company
Overview
20.4.3. Product
Offerings
20.4.4. Key
Developments
20.4.5. Financial
Analysis
20.4.6. SWOT
Analysis
20.4.7. Business Strategies
20.5. DB Schenker
20.5.1. Company
Details
20.5.2. Company
Overview
20.5.3. Product
Offerings
20.5.4. Key
Developments
20.5.5. Financial
Analysis
20.5.6. SWOT
Analysis
20.5.7. Business Strategies
20.6. DHL International GmbH
20.6.1. Company
Details
20.6.2. Company
Overview
20.6.3. Product
Offerings
20.6.4. Key
Developments
20.6.5. Financial
Analysis
20.6.6. SWOT
Analysis
20.6.7. Business Strategies
20.7. FedEx
20.7.1. Company
Details
20.7.2. Company
Overview
20.7.3. Product
Offerings
20.7.4. Key
Developments
20.7.5. Financial
Analysis
20.7.6. SWOT
Analysis
20.7.7. Business Strategies
20.8. GLOBAL COLD CHAIN SOLUTIONS PTY
LTD
20.8.1. Company
Details
20.8.2. Company
Overview
20.8.3. Product
Offerings
20.8.4. Key
Developments
20.8.5. Financial
Analysis
20.8.6. SWOT
Analysis
20.8.7. Business Strategies
20.9. KUEHNE + NAGEL
20.9.1. Company
Details
20.9.2. Company
Overview
20.9.3. Product
Offerings
20.9.4. Key
Developments
20.9.5. Financial
Analysis
20.9.6. SWOT
Analysis
20.9.7. Business Strategies
20.10. PAREXEL International
Corporation.
20.10.1. Company
Details
20.10.2. Company
Overview
20.10.3. Product
Offerings
20.10.4. Key
Developments
20.10.5. Financial
Analysis
20.10.6. SWOT
Analysis
20.10.7. Business Strategies
20.11. Quick International Courier
20.11.1. Company
Details
20.11.2. Company
Overview
20.11.3. Product
Offerings
20.11.4. Key
Developments
20.11.5. Financial
Analysis
20.11.6. SWOT
Analysis
20.11.7. Business Strategies
20.12. United Parcel Service of
America, Inc.
20.12.1. Company
Details
20.12.2. Company
Overview
20.12.3. Product
Offerings
20.12.4. Key Developments
20.12.5. Financial
Analysis
20.12.6. SWOT
Analysis
20.12.7. Business Strategies
20.13. Unsworth
20.13.1. Company
Details
20.13.2. Company
Overview
20.13.3. Product
Offerings
20.13.4. Key
Developments
20.13.5. Financial
Analysis
20.13.6. SWOT
Analysis
20.13.7. Business Strategies
20.14. Virgin Atlantic Airways
Ltd.
20.14.1. Company
Details
20.14.2. Company
Overview
20.14.3. Product
Offerings
20.14.4. Key
Developments
20.14.5. Financial
Analysis
20.14.6. SWOT
Analysis
20.14.7. Business Strategies
20.15. YUSEN LOGISTICS CO, LTD
20.15.1. Company
Details
20.15.2. Company
Overview
20.15.3. Product
Offerings
20.15.4. Key
Developments
20.15.5. Financial
Analysis
20.15.6. SWOT
Analysis
20.15.7. Business Strategies
20.16. Other
Industry Participants
21. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
